ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News

Tübingen/Schlieren (Switz­er­land) - SHS V, a fund mana­ged by Tübin­gen-based SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment, is inves­t­ing in Swiss evitria AG toge­ther with AFINUM. The life science company supplies large phar­maceu­ti­cal and biotech compa­nies with custom anti­bo­dies for rese­arch. For SHS, it is the first invest­ment from the SHS V fund, which had its first closing in July 2018.

evitria AG, based in Schlie­ren near Zurich, is a service provi­der for the produc­tion of custo­mi­zed anti­bo­dies. The company has a track record of more than 5,000 anti­body-based mole­cu­les produ­ced. evitria’s custo­mers are leading global phar­maceu­ti­cal compa­nies as well as acade­mic labo­ra­to­ries and biotech compa­nies from North America, Europe, Asia and Australia.

Many of the world’s top-selling drugs are thera­peu­tic anti­bo­dies. Accor­din­gly, drug deve­lo­pers are inten­si­vely rese­ar­ching further anti­body-based drugs against dise­a­ses such as cancer or neuro­lo­gi­cal disor­ders such as demen­tia. For this, they need specia­li­zed and relia­ble suppli­ers. The market in which evitria opera­tes will ther­e­fore conti­nue to grow dyna­mi­cally in the coming years.

SHS and AFINUM acquire a stake in evitria AG, which was foun­ded in 2010, with the aim of tapping into new custo­mer groups and estab­li­shing a busi­ness unit in the USA to serve the market there directly. This is the first joint invest­ment for SHS and AFINUM.

Corne­lius Maas, Senior Invest­ment Mana­ger at SHS, says: “We are very plea­sed to join forces with AFINUM and the expe­ri­en­ced manage­ment team to further deve­lop this fast-growing company inter­na­tio­nally. The anti­body produc­tion process at evitria is charac­te­ri­zed by high effi­ci­ency, quality and stabi­lity combi­ned with very short deli­very times. In short, evitria combi­nes an estab­lished, leading market posi­tion with high growth poten­tial. These charac­te­ristics guide all further invest­ments of our SHS‑V fund.”

About SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment mbH
Tübin­gen-based SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment invests in medi­cal tech­no­logy and life science compa­nies with a focus on expan­sion finan­cing, share­hol­der chan­ges and succes­sion situa­tions. In doing so, SHS enters into both mino­rity and majo­rity share­hol­dings. As an expe­ri­en­ced indus­try inves­tor, the company, which was foun­ded in 1993, supports the growth of its port­fo­lio compa­nies through a network of colla­bo­ra­ti­ons, for exam­ple in the intro­duc­tion of new products, regu­la­tory issues or entry into addi­tio­nal markets. The German and inter­na­tio­nal inves­tors in SHS funds include profes­sio­nal pension funds, pension funds, stra­te­gic inves­tors, funds of funds, family offices, entre­pre­neurs and the SHS manage­ment team. The equity invest­ment of the AIFM-regis­tered company is up to € 30 million, volu­mes excee­ding this can be imple­men­ted with a network of co-inves­tors. Follo­wing the first closing of SHS’s fifth fund of more than EUR 90 million in July 2018, invest­ments are alre­ady being made from the fund. The final closing will take place in July 2019.

www.shs-capital.eu

News

Berlin — The invest­ment company Odewald KMU II (board of direc­tors from left: Oliver Schön­knecht, Heiko Arnold, Joachim von Ribben­trop) acqui­res a majo­rity stake in GIATA GmbH. Since 1996, GIATA has been support­ing its custo­mers in the tourism indus­try as a leading provi­der of “non-booka­ble content”, conti­nuously setting new stan­dards in hotel content proces­sing and distri­bu­tion. The foun­ding share­hol­ders have taken a signi­fi­cant stake in the company and will remain at the company’s dispo­sal for the long term. Odewald KMU II was advi­sed by Heuking Kühn Lüer Wojtek.

Its modu­lar product range enables GIATA to offer complete solu­ti­ons tail­o­red to the indi­vi­dual custo­mer. In doing so, GIATA combi­nes inno­va­tive tech­no­lo­gies such as Arti­fi­cial Intel­li­gence and Digi­tal Finger­prin­ting with careful, manual rese­arch. Custo­mers from over 70 count­ries include almost all inter­na­tio­nally known tour opera­tors and travel agency chains, online travel agen­cies, the global travel distri­bu­tion systems and inter­na­tio­nally known travel portals. GIATA has thus estab­lished itself as the market leader in the market segments served by the company in the rapidly growing global tourism market.

To support further growth, the foun­ding share­hol­ders have ente­red into a part­ner­ship with Odewald KMU, Berlin, an invest­ment company specia­li­zing in high-growth medium-sized compa­nies. To this end, Odewald KMU has acqui­red a majo­rity stake in GIATA. The foun­ding share­hol­ders have taken a signi­fi­cant stake in the company and will remain at the company’s dispo­sal for the long term. The common goal of the share­hol­ders is to conti­nue to grow sustain­ably in the coming years with the exis­ting product range and to successfully posi­tion the product inno­va­tions curr­ently being laun­ched on the market. The parties have agreed not to disc­lose the amount of the invest­ment or further details of the shareholding.

The Odewald KMU II Fund has a volume of 200 million euros and invests in high-growth medium-sized compa­nies. The focus is on compa­nies in the fields of “German engi­nee­ring”, intel­li­gent services and health. Most recently, Odewald KMU II inves­ted in Langer & Laumann Inge­nieur­büro GmbH and heiz­ku­rier GmbH in Janu­ary 2018 with the support of Pär Johansson’s team. Kris­tina Schnei­der has also just successfully comple­ted the first add-on acqui­si­tion for heiz­ku­rier GmbH.

Advi­sor Odewald KMU II: Heuking Kühn Lüer Wojtek
Dr. Pär Johans­son (Lead), Kris­tina Schnei­der, LL.M., Dr. Chris­toph Schork, LL.M., Tim Remmel, LL.M. (all Private Equity, Corporate/M&A), all Colo­gne Dr. Sascha Sche­wiola (Labor Law), Dr. Verena Hoene, LL.M. (IP), both Colo­gne, Dr. Philip Kemper­mann, LL.M., Michael Kuska, LL.M., LL.M. (IT) both Düsseldorf.

News

Düsseldorf/Munich, Germany, Decem­ber 20, 2018 — ARQIS has appoin­ted Kozo Keikaku Engi­nee­ring Inc. (KKE) on its invest­ment in NavVis GmbH as part of a Series C finan­cing round with a total volume of around EUR 31.2 million, in which exis­ting inves­tors MIG, Target Part­ners, BayBG and Digi­tal+ Part­ners also participated.

NavVis is a leading global plat­form provi­der of intel­li­gent indoor posi­tio­ning tech­no­logy. Its revo­lu­tio­nary digi­tal twin plat­form is used by the world’s leading auto­mo­tive, cons­truc­tion, real estate and insu­rance compa­nies. NavVis was foun­ded in 2013 as a spin-off of the Tech­ni­cal Univer­sity of Munich and today has over 100 part­ners in more than 30 count­ries and employs more than 165 people world­wide. NavVis is head­quar­te­red in Munich and has offices in New York and Shanghai.

Kozo Keikaku Engi­nee­ring Inc. is a profes­sio­nal design and engi­nee­ring company in Japan enga­ged in a wide range of busi­ness acti­vi­ties, inclu­ding struc­tu­ral design of buil­dings (man-made struc­tures), analy­sis and simu­la­tion of natu­ral and envi­ron­men­tal pheno­mena (earth­qua­kes, tsuna­mis, wind, etc.), and problem solving of society and commu­ni­ties. Since 2015, KKE has alre­ady coope­ra­ted with NavVis and intro­du­ced its products to the Japa­nese market. Both compa­nies now intend to inten­sify their coope­ra­tion through the finan­cial parti­ci­pa­tion of KKE.

Advi­sors to Kozo Keikaku Engi­nee­ring: ARQIS Rechts­an­wälte (Düsseldorf/Munich)
Prof. Dr. Chris­toph von Einem (photo), Dr. Meiko Dill­mann (both lead; Corporate/M&A; Munich), Dr. Shigeo Yama­guchi (Corporate/M&A; Düssel­dorf); Asso­cia­tes: Florian Kotman (Corporate/M&A; Düsseldorf)

About ARQIS
ARQIS is an inde­pen­dent busi­ness law firm opera­ting in Germany and Japan. The firm was foun­ded in 2006 at its current offices in Düssel­dorf, Munich and Tokyo. Around 45 profes­sio­nals advise dome­stic and foreign compa­nies at the highest level on the core issues of German and Japa­nese busi­ness law. The focus is on M&A, corpo­rate law, private equity, venture capi­tal, employ­ment law, private clients, intellec­tual property, liti­ga­tion as well as real estate law and tax law. For more infor­ma­tion, visit www.arqis.com.

News

Berlin — The Euro­pean Invest­ment Bank (EIB) has inves­ted EUR 50 million in the German venture capi­tal fund copa­rion. copa­rion was origi­nally laun­ched by the ERP Special Fund (German Fede­ral Minis­try for Econo­mic Affairs and Energy) and KfW with a volume of EUR 225 million. The EIB’s parti­ci­pa­tion now increa­ses the fund volume to EUR 275 million.

As a co-invest­ment fund, copa­rion invests in young, high-growth and tech­no­logy-orien­ted compa­nies toge­ther with private sector inves­tors, ther­eby support­ing the venture capi­tal market in Germany. Through the co-invest­ments, the inten­ded total invest­ment volume of copa­rion (toge­ther with co-inves­tors) amounts to appro­xi­m­ately EUR 550 million.

The EIB is a long-term lending insti­tu­tion of the Euro­pean Union whose share­hol­ders are the EU Member States. The invest­ment in copa­rion is linked to the goal of streng­thening the emer­ging venture capi­tal market in Germany as well. The invest­ment is part of the so-called Invest­ment Offen­sive for Europe (“Juncker Plan”), which aims to create jobs by inves­t­ing in Europe.

Advi­sing EIB: P+P Pöllath + Part­ners provi­ded compre­hen­sive contrac­tual, tax, regu­la­tory and corpo­rate law advice to EIB in complex nego­tia­ti­ons on its invest­ment in copa­rion with the follo­wing private funds team.
Tarek Mardini (photo), LL.M. (UConn), Part­ner (Lead Part­ner, Private Funds, Berlin), Dr. Chris­tian Hille­brand, M.Litt. (St. Andrews), Senior Asso­ciate (Private Funds, Berlin), Dr. Joachim Mogck, LL.M. (San Fran­cisco), Senior Asso­ciate (Private Funds, Berlin).

Inhouse legal advice to the EIB was provi­ded by Dr. Chris­toph Diesel and Thomas Lugez.

Advi­sor to copa­rion: Dr. Wolf­gang Weit­nauer (Weit­nauer Rechts­an­wälte, Munich).

News

Martins­ried — High-Tech Grün­der­fonds and Think.Health Ventures, toge­ther with busi­ness angels, invest 3.3 million euros in a Series A for the growth of PreO­mics in Martins­ried. PreO­mics deve­lops and produ­ces inno­va­tive tech­no­lo­gies for the preana­ly­tics of samples for mass spec­tro­me­try. Today, sample proces­sing for mass spec­tro­me­try is usually perfor­med accor­ding to home­made proto­cols. These proces­ses are slow, not repro­du­ci­ble, not robust and cannot be auto­ma­ted. These solu­ti­ons are ther­e­fore very time-consum­ing and costly, which can even lead to the loss of valuable samples.

PreO­mics addres­ses these issues through a stan­dar­di­zed tech­no­logy that enables robust and repro­du­ci­ble results in sample prepa­ra­tion. Addi­tio­nally, the proto­cols have a signi­fi­cantly redu­ced workload compared to tradi­tio­nal prac­ti­ces. As part of the seed invest­ment with High-Tech Grün­der­fonds and busi­ness angels, the first products were brought to market and new products were deve­lo­ped. For this purpose, foun­ders Garwin Pich­ler and Nils Kulak have built up a team at the IZB faci­li­ties in Martins­ried and formed part­ner­ships for produc­tion and further deve­lo­p­ment. Think.Health Ventures is now leading another finan­cing round of €3.3 million to support the further inter­na­tio­na­liza­tion of the busi­ness and the deve­lo­p­ment of addi­tio­nal products.

Dr. Garwin Pich­ler, Mana­ging Direc­tor at PreO­mics, said, “Custo­mers world­wide use our tech­no­lo­gies that enable stan­dar­di­zed and effi­ci­ent sample prepa­ra­tion for protein analy­sis and offer a signi­fi­cant cost-bene­fit advan­tage. With the new capi­tal, we intend to acce­le­rate the expan­sion of global sales with a focus on the U.S. and the deve­lo­p­ment of new products.”

Dr. Fabian Mohr, Invest­ment Mana­ger at HTGF: “We are very exci­ted to co-invest in the Series A to build on the success of the seed round. The company has made a great deve­lo­p­ment and we trust in the leader­ship team for further market expan­sion and product development.”

For Dr. Michael Ruoff (photo), part­ner at Think Health Ventures, the main factor contri­bu­ting to the invest­ment was “the effec­tive solu­tion to a clear problem with posi­tive market feed­back combi­ned with the exper­tise and ambi­tion of the entire team.” “We see great poten­tial with PreO­mics to acce­le­rate drug deve­lo­p­ment for serious dise­a­ses, as their products curr­ently have an outstan­ding market position.”

About PreO­mics
The company was spun out in August 2016 with intellec­tual property from Matthias Mann’s lab at the Max Planck Insti­tute of Bioche­mis­try. Since then, new products have been deve­lo­ped, which have been protec­ted with their own IP. The mana­ging direc­tors Garwin Pich­ler and Nils Kulak are supported by an advi­sory board with a wealth of expe­ri­ence in the life scien­ces. PreO­mics’ mission is to bring the gold stan­dard for preana­ly­tics in mass spec­tro­me­try to market.

About High-Tech Gründerfonds
The seed inves­tor High-Tech Grün­der­fonds (HTGF) finan­ces tech­no­logy start­ups with growth poten­tial. With a total volume of 892.5 million euros distri­bu­ted across three funds and an inter­na­tio­nal part­ner network, HTGF has alre­ady supported more than 500 start­ups since 2005. His team of expe­ri­en­ced invest­ment mana­gers and startup experts supports the young compa­nies with know-how, entre­pre­neu­rial spirit and passion. The focus is on high-tech start-ups in the hard­ware, soft­ware, life scien­ces and chemi­cal indus­tries. More than €1.9 billion in capi­tal has been inves­ted in the HTGF port­fo­lio by exter­nal inves­tors in around 1,400 follow-on finan­cing rounds to date. In addi­tion, the fund has now successfully sold shares in 100 companies.

Inves­tors in the public-private part­ner­ship include the German Fede­ral Minis­try for Econo­mic Affairs and Energy, KfW, the Fraun­ho­fer-Gesell­schaft and the busi­ness enter­pri­ses ALTANA, BASF, Bayer, Boeh­rin­ger Ingel­heim, B.Braun, Robert Bosch, BÜFA, CEWE, Deut­sche Post DHL, Dräger, Dril­lisch AG, EVONIK, EWE AG, Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Betei­li­gungs GmbH & Co. KG, PHOENIX CONTACT, Post­bank, QIAGEN, RWE Gene­ra­tion SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Infor­ma­tik, WACKER and Wilh. Werhahn KG.

About Think.Health.com
Think.Health invests as a boutique risk-taker in health­care ventures. We conti­nuously seek inno­va­tions and disrup­tive busi­ness models in digi­tal health­care, medi­cal tech­no­lo­gies and health service provi­ders. We typi­cally invest in early stage ventures and growth oppor­tu­ni­ties ranging from € 200k to € 2m. We are an active and hands-on inves­tor and provide strong support to our manage­ment teams.

News

Berlin/ Kufstein — The Tyro­lean company Green­storm can be plea­sed about a multi-million invest­ment: the Euro­pean private equity firm Bregal Mile­stone invests a double-digit million amount. Green­storm is a fast-growing provi­der in the field of e‑mobility and alre­ady coope­ra­tes with nearly 1,000 hotels, retail­ers and busi­nesses in seve­ral Euro­pean count­ries. The company opera­tes a large fleet of e‑bikes and makes it possi­ble to offer e‑bikes and e‑cars to its custo­mers, guests and employees. Hotel busi­nesses in parti­cu­lar bene­fit from this by incre­asing their occu­p­ancy rates and gene­ra­ting addi­tio­nal reve­nue. Follo­wing the rental, the bikes that have been used by the custo­mers are compre­hen­si­vely serviced and resold to the specia­li­zed trade and private indi­vi­du­als. The inno­va­tive combi­na­tion of trends in e‑mobility and tourism ensu­res Green­strom a market-leading posi­tion and makes it one of the fastest growing compa­nies in Austria.

Coope­ra­tion to acce­le­rate development
Greenstorm’s mana­ging direc­tors Richard Hirsch­hu­ber and Phil­ipp Zimmer­mann (photo) want to use the coope­ra­tion with Bregal Mile­stone to once again acce­le­rate the company’s growth, drive expan­sion and further deve­lop the e‑commerce offe­ring. With the networ­king of e‑mobility and tourism, the company wants to be a leader in Europe. Green­storm has recei­ved seve­ral awards for its deve­lo­p­ment in its still young past — such as the German Inno­va­tion Award and the Tyro­lean Inno­va­tion Award. The team has been active in the mobi­lity sector since 2009, and Green­storm is curr­ently repre­sen­ted in Austria, Germany, Switz­er­land, Italy, Croa­tia and Slovenia.

“Bregal Milestone’s invest­ment and hands-on support will help us achieve our ambi­tious growth targets. We are plea­sed to have found an entre­pre­neu­rial part­ner with a broad inter­na­tio­nal network. In the coming years, we will expand the successful Green­storm model to addi­tio­nal custo­mers and new regi­ons, extend our leader­ship in the field of elec­tro­mo­bi­lity, and build a strong cross-natio­nal e‑commerce presence,” empha­size Greenstorm’s mana­ging direc­tors Richard Hirsch­hu­ber and Phil­ipp Zimmermann.

“We are exci­ted to work with the Green­storm team to launch the next phase of growth. Green­storm offers a unique e‑mobility propo­si­tion to its custo­mers and the team’s stra­tegy will drive strong growth in the coming years. Greenstorm’s e‑commerce presence in the mobi­lity and travel space is parti­cu­larly promi­sing. We look forward to working toge­ther to further deve­lop this aspect of the busi­ness and deli­ver profi­ta­ble growth,” commen­ted Jan Bruenn­ler, Mana­ging Part­ner at Bregal Mile­stone. The capi­tal comes from Bregal Milestone’s €400 million fund dedi­ca­ted to invest­ments in high-growth Euro­pean compa­nies. The invest­ment volume is usually between 20 and 60 million euros.

About Green­storm
Green­storm Mobi­lity GmbH from Kufstein, Austria, provi­des its custo­mers with e‑bikes, elec­tric cars as well as char­ging stati­ons with an inno­va­tive rental concept. Greenstorm’s custo­mers include hotels, compa­nies and retail­ers in Austria, Italy, Germany, Switz­er­land, Croa­tia and Slove­nia. The hotel indus­try gene­ra­tes addi­tio­nal reve­nue and achie­ves higher occu­p­ancy rates by working with Green­storm. At the end of the rental period, the company services the used top-of-the-line e‑bikes and offers them for sale. Here, Green­storm has set itself the goal of beco­ming Europe’s largest dealer network for used top e‑bikes. With this concept, Green­storm addres­ses not only B2B custo­mers such as hote­liers and sports retail­ers, but also end customers.

Curr­ently, the company employs 59 people. In 2017, it achie­ved fourth place in the growth ranking of Austrian compa­nies. This year, Green­storm not only recei­ved the Tyro­lean Inno­va­tion Award, but was also hono­red with the German Inno­va­tion Award. In addi­tion, Green­storm was among the fina­lists of the EY Entre­pre­neur Of The Year compe­ti­tion in the “Start-ups” cate­gory. Inter­na­tio­nally, the company is on an expan­sion course and, in addi­tion to Austria, Germany, Switz­er­land and Italy, has also been active in Croa­tia and Slove­nia since 2018. www.greenstorm.eu

Consul­tant Greenstorm: 
Reed Smith and Eisen­ber­ger & Herzog as legal counsel.

Consul­tant Bregal Milestone:
Shear­man & Ster­ling, Dorda Attor­neys at Law, EY, Deloitte and OC&C Stra­tegy Consul­tants supported.

News

Munich, London, Paris — Follo­wing its invest­ment in the West­pha­lian company 7days at the begin­ning of the year, the Euro­pean private equity firm Silver­fleet Capi­tal is start­ing to imple­ment its buy & build stra­tegy: With the support of Silver­fleet Capi­tal, the specia­list for work­wear in the health­care sector is taking over the Danish company Praxis Herning A/S, thus opening up addi­tio­nal sales markets. The private sellers of the majo­rity shares also include the two mana­ging direc­tors Jesper Rasmus­sen and Søren Wort­mann, who will conti­nue to remain on board in their func­tions and take a retroac­tive stake. The parties have agreed not to disc­lose the purchase price.

Praxis was foun­ded in 1995 and is based in the Danish textile capi­tal Herning. The company specia­li­zes in the design, produc­tion and distri­bu­tion of clot­hing for health­care profes­sio­nals. The product port­fo­lio includes tops such as t‑shirts or polo shirts, pants and shoes. Praxis prima­rily serves custo­mers from the Scan­di­na­vian region (Sweden, Norway, Finland) in addi­tion to Denmark.

Foun­ded in 1999, 7days from Lotte near Osna­brück is one of Europe’s leading specia­lists in medi­cal work­wear. A parti­cu­lar focus of the product range, which compri­ses more than 2,000 artic­les, is on furnis­hing medi­cal and dental prac­ti­ces in Germany, Austria, Switz­er­land, France, Belgium and the Nether­lands. Simi­lar to Praxis, 7days markets its items online via webshop and news­let­ter as well as via catalog.

Joachim Braun, Part­ner at Silver­fleet Capi­tal and respon­si­ble for 7days, says: “7days and Praxis are ideal part­ners based on their focus, stra­tegy and busi­ness philo­so­phy. Both stand for high-quality mate­ri­als and work­man­ship as well as opti­mal comfort at an attrac­tive price-perfor­mance ratio. The tie-up is the first step in our growth stra­tegy for 7days, which aims to streng­then our dome­stic market posi­tion as well as tap into other regi­ons and addi­tio­nal custo­mer segments.”

“With Praxis, we have found the perfect part­ner for ente­ring the Scan­di­na­vian market,” say Cars­ten Meyer and Ulrich Dölken, the mana­ging direc­tors of 7days. “We are now a big step closer to our goal of further expan­ding our market leader­ship in Europe. We are very plea­sed to bring Jesper and Søren on board, as both our busi­ness model and our busi­ness culture are a perfect fit.”

Jesper Rasmus­sen, Mana­ging Direc­tor of Praxis: “It is great to now become part of the 7days Group with our company Praxis. 7days is a strong part­ner with whom we want to leverage many more market and sales poten­ti­als from now on.”

The Silver­fleet team entrus­ted with the tran­sac­tion includes Munich-based invest­ment experts Joachim Braun, Benja­min Hubner and Jan Kux.
7days was advi­sed by McDer­mott (Legal Corpo­rate, Germany), Moalem Weitemeyer Bendt­sen (Legal Corpo­rate, Denmark), Latham & Watkins (Legal Tax), Shear­man & Ster­ling (Legal Finan­cing) and Deloitte (Finan­cial & Tax Denmark).

About Silver­fleet Capital
Silver­fleet Capi­tal has been active as a private equity inves­tor in the Euro­pean mid-market for more than 30 years and curr­ently mana­ges around €1.2 billion with its 30-strong invest­ment team in Munich, London, Paris, Stock­holm and Amsterdam.

Eight invest­ments have alre­ady been made from the second inde­pen­dent fund closed in 2015 with a volume of 870 million euros: The Masai Clot­hing Company, a women’s fashion whole­sa­ler and retailer head­quar­te­red in Denmark; Coven­tya, a French deve­lo­per of specialty chemi­cals; Sigma Compon­ents, a U.K. manu­fac­tu­rer of precis­ion compon­ents for civil avia­tion; Life­time Trai­ning, a U.K. provi­der of trai­ning programs; Pumpen­fa­brik Wangen, a manu­fac­tu­rer of specialty pumps based in Germany; Riviera Travel, a British opera­tor of escor­ted group tours and crui­ses; 7days, a West­pha­lian supplier of medi­cal work­wear; and Prefere Resins, a leading phen­o­lic and amino resin manu­fac­tu­rer in Europe.

Silver­fleet achie­ves value growth through its “buy to build” invest­ment stra­tegy. As part of this stra­tegy, Silver­fleet is acce­le­ra­ting the growth of its subsi­dia­ries by inves­t­ing in new products, produc­tion capa­city and employees, instal­ling successful retail formats or making follow-up acqui­si­ti­ons. Since 2004, Silver­fleet Capi­tal has inves­ted €1.9 billion in 28 companies.

Silver­fleet specia­li­zes in four key indus­tries: Busi­ness and Finan­cial Services, Health­care, Manu­fac­tu­ring, and Retail and Consu­mer Goods. Since 2004, the private equity inves­tor has inves­ted 33 percent of its assets in compa­nies head­quar­te­red in the DACH region, 31 percent in the UK and Ireland, 19 percent in Scan­di­na­via and 17 percent mainly in France and the Bene­lux count­ries (1).

News

Aachen — S‑UBG AG, Unter­neh­mens­be­tei­li­gungs-Gesell­schaft für die Regio­nen Aachen, Krefeld und Mönchen­glad­bach, toge­ther with its new mana­ging direc­tor Ralph Bauer, acqui­res 100 percent of the shares in Schif­fer Service GmbH as part of a manage­ment buy-in. As his succes­sor, Ralph Bauer will take over the sole manage­ment of the logi­stics company from foun­der Rolf Schif­fer as of 01.01.2019. In the future share­hol­der struc­ture, S‑UBG will hold 25 percent of the company’s shares.

Busi­ness areas with strong sales
Rolf Schif­fer foun­ded Schif­fer Service GmbH in 1995, from which today’s core busi­ness emer­ged. This is divi­ded into the three areas of logi­stics, pack­a­ging and fulfill­ment (order proces­sing in e‑commerce). Fulfill­ment employees take care of accep­ting orders, picking, pack­ing goods and products, as well as ship­ping to the end custo­mer and subse­quent returns manage­ment. More than half of the company’s sales are gene­ra­ted here.

“Online trade — and with it the mail-order busi­ness — has been growing steadily for years,” says Ralph Bauer. “Howe­ver, many retail­ers do not see their core compe­tence in logi­stics, but in bran­ding as well as marke­ting and shy away from corre­spon­ding invest­ments. Here, the fulfill­ment we offer is a suita­ble solution.”

After the take­over, Rolf Schif­fer will be available as a consul­tant for another three months, ensu­ring a tran­si­tion without loss of know-how and know­ledge. His succes­sor, Ralph Bauer, gained years of expe­ri­ence in sales and marke­ting after gradua­ting with a degree in busi­ness admi­nis­tra­tion. The 50-year-old took on person­nel manage­ment tasks at an early stage in both family-owned compa­nies and multi­na­tio­nal corpo­ra­ti­ons, was a member of the manage­ment board and is thus ideally prepared for his new task.

Deputy remains on board
“Due to the product and service diver­si­fi­ca­tion in recent years, Schif­fer Service GmbH is very well posi­tio­ned,” says Bern­hard Kugel (photo), CEO of the S‑UBG Group. “High flexi­bi­lity, relia­bi­lity and long-stan­ding custo­mer rela­ti­onships help the company to build a good repu­ta­tion that gene­ra­tes many custo­mer inqui­ries. In addi­tion, Schif­fer is active in growth markets with all three busi­ness units, and so we expect the busi­ness to conti­nue to deve­lop healt­hily and successfully in the future,” adds Günther Bogen­rie­der, who closely accom­pa­nied the take­over as S‑UBG’s project manager.

“Thanks to the strong network of my succes­sor Ralph Bauer, the company will conti­nue to grow and streng­then its core compe­ten­cies in the future,” Rolf Schif­fer is certain. “In addi­tion, we are also solidly posi­tio­ned at the manage­ment level with Michael Pauly, Deputy Mana­ging Direc­tor and entrus­ted with the busi­ness for more than 15 years.”

About S‑UBG Group:
The S‑UBG Group, Aachen, has been the leading part­ner in the provi­sion of equity capi­tal for estab­lished medium-sized compa­nies (S‑UBG AG) and young, tech­no­logy-orien­ted start-ups (S‑VC GmbH) in the econo­mic regi­ons of Aachen, Krefeld and Mönchen­glad­bach for over 30 years. S‑UBG AG invests in growth sectors; high quality of corpo­rate manage­ment is a key invest­ment criter­ion for the invest­ment company. In 1997, the share­hol­der savings banks estab­lished an early-stage fund under S‑VC GmbH to finance startups.

In 2018, toge­ther with Spar­kasse Aachen, Kreis­spar­kasse Heins­berg, Stadt­spar­kasse Mönchen­glad­bach, NRW.BANK and DSA Invest GmbH, Seed Fonds III für die Region Aachen & Mönchen­glad­bach GmbH & Co. KG was laun­ched, provi­ding around 21.5 million euros in seed capi­tal for the start-up scene in the region. As the succes­sor to the two fully finan­ced seed funds, it stimu­la­tes the deve­lo­p­ment of future-orien­ted tech­no­lo­gies in the Aachen econo­mic region and was exten­ded to the Mönchen­glad­bach region in 2018. The S‑UBG Group curr­ently holds stakes in over 40 compa­nies in the region, giving it a top posi­tion in the Spar­kas­sen-Finanz Group. Further infor­ma­tion: www.s‑ubg.de; www.seedfonds-aachen.de

News

Eschborn/ Vienna - Gleiss Lutz advi­sed BAWAG Group on the conclu­sion of a binding agree­ment for the full acqui­si­tion of BFL Leasing GmbH from BFL Gesell­schaft des Büro­fach­han­dels mbH & Co KG. The majo­rity share­hol­der is VR-LEASING AG. The closing of the tran­sac­tion is subject to custo­mary regu­la­tory appr­ovals. The parties have agreed not to disc­lose the purchase price or the details of the contract.

BFL Leasing GmbH, head­quar­te­red in Esch­born near Frank­furt, Germany, is a specia­li­zed finan­cing provi­der offe­ring leasing services and products for tech­no­logy and equip­ment since 1973. The company comple­ments the BAWAG Group’s busi­ness model with its sales model and at the same time offers the oppor­tu­nity to grow in the leasing busi­ness in Germany.

BFL Leasing GmbH curr­ently employs around 75 people, and its total assets amoun­ted to around EUR 600 million at the end of 2017. For more than 40 years, BFL Leasing GmbH has been deve­lo­ping finan­cing solu­ti­ons for retail and system houses as well as manu­fac­tu­r­ers. Today, it has more than 140 part­ners and, with its sales part­ners and around 50,000 custo­mers, is one of the leading IT finan­cing specia­lists in Germany. As a subsi­diary of VR-LEASING Akti­en­ge­sell­schaft, BFL is part of the Genos­sen­schaft­li­che Finanz­Gruppe, the second largest banking group in Germany.

BAWAG Group AG is the listed holding company of BAWAG P.S.K., head­quar­te­red in Vienna, and its main banking subsi­dia­ries easy­bank and start:bausparkasse in Austria and Südwest­bank in Germany. With more than 2.5 million custo­mers, BAWAG P.S.K. is one of the largest banks in Austria and has a natio­nally reco­gni­zed brand. BAWAG Group repor­ted total assets of around EUR 46 billion at the end of 2017.

Advi­sor BAWAG: Gleiss Lutz 
Led by Dr. Jan Bals­sen (Part­ner, Corporate/M&A); Dr. Olaf Hohle­fel­der, Stepha­nie Daus­in­ger (both Corporate/M&A), Stef­fen Carl (Part­ner), Dr. Tobias Harzenet­ter (Coun­sel, both Corpo­rate, all Munich), Dr. Alex­an­der Molle (Coun­sel), Dr. Matthias Schilde, (both IP/IT, Berlin), Anselm Chris­ti­an­sen (Stutt­gart, Corporate/M&A), Dr. Stefan Mayer (Part­ner), Dr. Ocka Stumm (both Tax), Dr. Jens Günther (Part­ner), Dr. Matthias Bögl­mül­ler (both Labor), Dr. Iris Bene­dikt-Bucken­leib (Coun­sel, Anti­trust, all Munich), Dr. Timo Bühler (Banking Regu­la­tory), Dr. Burk­hard Jäkel (Part­ner), Vanessa Bayliss (Coun­sel), Dr. Moha­med Assak­kali (all Finance/Leasing), Dr. Philip Naab (Coun­sel, Real Estate), Dr. Dirk
Scherp (Of Coun­sel), Marina Stoklasa (both Compli­ance & Inves­ti­ga­ti­ons, all Frank­furt), Dr. Jacob von Andreae (Part­ner), Aylin Hoffs (both Düssel­dorf, Public Law), Simon Wegmann (Data Protec­tion Law, Berlin) Dr. Britta Kamp (Commer­cial Contracts, Stuttgart).

News

Düssel­dorf — ARQIS advi­sed AVS Verkehrs­si­che­rung GmbH (“AVS”), a port­fo­lio company of Triton Fund IV, on the acqui­si­tion of Traf­fics A/S (“Traf­fics”), a Danish provi­der in the field of cons­truc­tion site and traf­fic safety based in Gads­trup (Denmark). The parties have agreed not to disc­lose the purchase price.

Traf­fics A/S was estab­lished in 2006 and offers complete solu­ti­ons and services as well as all kinds of access­ories rela­ted to site and traf­fic safety. Custo­mers include road cons­truc­tion compa­nies as well as muni­ci­pa­li­ties and govern­ment cons­truc­tion projects in Denmark.

“We have a long-stan­ding and trus­ting busi­ness rela­ti­onship with Traf­fics. Toge­ther, AVS and Traf­fics can offer their custo­mers in the Danish market a compre­hen­sive product and service port­fo­lio that meets the highest stan­dards,” says Dirk Schö­nauer, Mana­ging Direc­tor of AVS.

AVS is a leading specia­list provi­der of traf­fic safety services in Germany, espe­ci­ally of major projects on fede­ral high­ways. The company is head­quar­te­red in Kürten, Germany, and has been a one-stop provi­der of complete services for traf­fic safety projects for more than 30 years. These range from initial plan­ning and obtai­ning permits to complete site cons­truc­tion and safety aspects. AVS has a nati­on­wide presence with 14 loca­ti­ons throug­hout Germany and employs appro­xi­m­ately 600 people.

This is the third trans­ca­tion that ARQIS has accom­pa­nied for AVS. In Octo­ber 2018, Jörn-Chris­tian Schulze’s team advi­sed AVS on the acqui­si­tion of Verkehrs­si­che­run­gen Plank GmbH, based in Rems­eck am Neckar, a provi­der in the field of cons­truc­tion site and traf­fic safety. In August 2018, ARQIS assis­ted AVS in the acqui­si­tion of KMK projects, a leading provi­der of road safety products as well as perma­nent road marking in Latvia.

Danish law was hand­led by Poul Schmith. Anders Kjær Dybdahl’s team had alre­ady assis­ted in the acqui­si­tion of a Danish company for another ARQIS client earlier in 2018.

Advi­sors AVS Verkehrs­si­che­rung GmbH: ARQIS Rechts­an­wälte (Düssel­dorf)
Dr. Jörn-Chris­tian Schulze, Photo (Lead; Corporate/M&A); Asso­cia­tes: Caro­lin Schlüt­ter (M&A), Carina Engel­hard (Labor Law)

Danish law: Poul Schmith
Anders Kjær Dybdahl (lead), Thomas Bento-Nystad, Line Sten­strup de Heus Kronsbjerg (all Corporate/M&A)

About ARQIS
ARQIS is an inde­pen­dent busi­ness law firm opera­ting in Germany and Japan. The firm was foun­ded in 2006 at its current offices in Düssel­dorf, Munich and Tokyo. Around 45 profes­sio­nals advise dome­stic and foreign compa­nies at the highest level on the core issues of German and Japa­nese busi­ness law. The focus is on M&A, corpo­rate law, private equity, venture capi­tal, employ­ment law, private clients, intellec­tual property, liti­ga­tion as well as real estate law and tax law.

News

Solingen/ Munich — AFINUM Achte Betei­li­gungs­ge­sell­schaft mbH & Co. KG, advi­sed by Munich-based AFINUM Manage­ment GmbH, acqui­res as lead inves­tor and majo­rity share­hol­der toge­ther with INVISION and the manage­ment team Ledlen­ser GmbH & Co. KG (“Ledlen­ser”) from Leather­man Tool Group, Inc. (“Leather­man”). The parties have agreed not to disc­lose the volume of the transaction.

Head­quar­te­red in Solin­gen, Germany, with produc­tion faci­li­ties in Yanjiang, China, Ledlen­ser (www.ledlenser.com) is one of the world’s leading manu­fac­tu­r­ers of high-quality LED flash­lights and head­lamps for profes­sio­nal, outdoor and ever­y­day appli­ca­ti­ons. The company was foun­ded in 1994 and is conside­red the inven­tor of the LED flash­light. The products are charac­te­ri­zed by a high degree of inno­va­tion, by outstan­ding quality and by an appe­al­ing design. The company secu­res its compre­hen­sive know-how with a strong rese­arch and deve­lo­p­ment depart­ment and more than 100 patents. End custo­mers include indus­trial compa­nies, public orga­niza­ti­ons — such as police or fire depart­ments — and outdoor enthu­si­asts. The company holds a strong market posi­tion in nume­rous count­ries in Europe and Asia.

Toge­ther with the manage­ment team, AFINUM and INVISION plan to push ahead with inter­na­tio­na­liza­tion in the coming years. Like­wise, conti­nuous product inno­va­tions are inten­ded to win addi­tio­nal custo­mers in the various end markets. The invest­ment in Ledlen­ser repres­ents the fourth plat­form invest­ment of AFINUM Achte Betei­li­gungs­ge­sell­schaft mbH & Co KG. AFINUM is an inde­pen­dent manage­ment-owned invest­ment company with offices in Munich, Zurich, Vienna and Hong Kong, specia­li­zing in invest­ments in successful medium-sized compa­nies in German-spea­king Europe.

Advi­sor to seller Kloft Leather­man: Taylor Wessing
Inter­na­tio­nal law firm Taylor Wessing, led by Hamburg-based part­ner Bern­hard Kloft, provi­ded legal advice to Leather­man on the sale as part of a struc­tu­red bidding process.

News

Munich — Golding Capi­tal Part­ners (Golding) has alre­ady recei­ved € 215 million in capi­tal commit­ments for its infra­struc­ture invest­ment program Golding Infra­struc­ture 2018 at first closing. With the third gene­ra­tion of the invest­ment stra­tegy deve­lo­ped in 2012 and proven in two prede­ces­sor funds, Golding under­lines its posi­tion as one of the leading inde­pen­dent provi­ders of infra­struc­ture invest­ments in Europe.

The Golding Infra­struc­ture 2018 invest­ment program follows a conser­va­tive invest­ment stra­tegy and offers early ongo­ing distri­bu­ti­ons with an attrac­tive total port­fo­lio yield of 7% to 8% p.a. Net IRR. The fund plans to build up a broadly diver­si­fied port­fo­lio of around 200 infra­struc­ture projects in the Euro­pean and North Ameri­can markets. At the same time, important sectors such as energy, trans­por­ta­tion, utili­ties and social infra­struc­ture are to be covered by the port­fo­lio. Invest­ments are plan­ned in around 15 infra­struc­ture funds (prima­ries and secon­da­ries) with a focus on conser­va­tive core / core plus invest­ments and brown­field projects as well as selec­tive co-invest­ments. Co-invest­ments in parti­cu­lar offer insti­tu­tio­nal inves­tors the oppor­tu­nity to achieve a targe­ted geogra­phic or secto­ral focus and thus support a rapid port­fo­lio build-up.

Golding was able to attract a total of 20 insti­tu­tio­nal inves­tors for the current invest­ment program at the first closing. Inves­tors include insu­rance compa­nies, pension funds, banks and savings banks. Almost 80 percent of the volume was subscri­bed by exis­ting inves­tors in the two infra­struc­ture prede­ces­sor funds. “We are plea­sed with the strong recep­tion and contin­ued confi­dence of our inves­tors. We have main­tai­ned our conser­va­tive stra­te­gic approach and have high-performing and distri­bu­tion-orien­ted port­fo­lios,” said Huber­tus Theile-Ochel, Mana­ging Direc­tor at Golding. “Long-stan­ding port­fo­lio rela­ti­onships and substan­tial subscrip­tion levels make us a rele­vant part­ner even for mana­gers who are in high demand. From this, we gene­rate signi­fi­cant advan­ta­ges for our inves­tors. We have alre­ady been able to subscribe to three high-cali­ber target funds for the current program,” adds Dr. Matthias Reicher­ter, Chief Invest­ment Offi­cer at Golding. Further invest­ments for the coming months are alre­ady under review. Over­all, the port­fo­lio is to be built up over around three years with broad diversification.

The attrac­ti­ve­ness of the infra­struc­ture asset class has led to an increase in compe­ti­tion. This is why infra­struc­ture funds must also incre­asingly engage in complex tran­sac­tions and correctly assess project risks in order to achieve the returns and distri­bu­tion levels expec­ted by inves­tors. Deal sourcing is beco­ming the defi­ning issue. “Only expe­ri­en­ced teams can handle comple­xity respon­si­bly and achieve an attrac­tive risk-adequate return,” Reicher­ter explains. Against this back­drop, Golding’s infra­struc­ture team focu­ses on specia­list fund mana­gers with diffe­ren­tia­ted stra­tegy, in-depth market know­ledge and estab­lished network, who are able to execute complex tran­sac­tions and thus iden­tify attrac­tive deals even in an increased compe­ti­tive environment.

“The current envi­ron­ment requi­res a lot of exper­tise and strong market access. Despite fierce compe­ti­tion and the huge volume of invest­ments gathe­ring in capi­tal markets world­wide, Golding was able to secure attrac­tive invest­ments — both prima­ries and complex struc­tu­red secon­da­ries as well as co-invest­ments. As a result, we have alre­ady succee­ded in inves­t­ing around 800 million euros in the infra­struc­ture asset class alone since the begin­ning of the year,” comm­ents Jeremy Golding (photo), foun­der and CEO of Golding.

About Golding Capi­tal Partners
Golding Capi­tal Part­ners GmbH is one of the leading inde­pen­dent asset mana­gers for private equity, private debt and infra­struc­ture in Europe. With a team of around 90 employees in Munich, Luxem­bourg, New York and Tokyo, Golding Capi­tal Part­ners supports insti­tu­tio­nal inves­tors in buil­ding their invest­ment stra­tegy and mana­ges assets of more than €7 billion. The more than 160 insti­tu­tio­nal inves­tors include insu­rance compa­nies, pension funds, foun­da­ti­ons as well as banks, savings banks and coope­ra­tive banks.

News

Munich — FSN Capi­tal V (“FSN”) acqui­res the majo­rity shares in the Rame­der Group. A corre­spon­ding purchase agree­ment was signed with the previous share­hol­ders. Rame­der has been active since 1996 and, with 200 employees, is one of the leading B2B and B2C dealers in the areas of trai­ler hitches, bicy­cle racks and roof boxes in Europe. The two mana­ging direc­tors Dirk Schö­ler and Stefan Bertels­ho­fer remain share­hol­ders in the Rame­der Group as part of a reverse shareholding.

FSN is one of the leading private equity inves­tors in Scan­di­na­via with a focus on medium-sized compa­nies. In addi­tion to offices in Oslo, Stock­holm and Copen­ha­gen, FSN has had an office in Munich since spring 2018. The acqui­si­tion of a majo­rity stake in Rame­der is FSN’s first tran­sac­tion in Germany.

Advi­sor FSN Capi­tal: Henge­ler Muel­ler provi­ded compre­hen­sive advice to FSN on the transaction.
The part­ners Dr. Daniel Wiegand (lead), Dr. Daniel Möritz (both Corporate/M&A, Munich), Daniela Böning (Finan­cing), Hendrik Bocken­hei­mer (Labor Law) (both Frank­furt) and Dr. Thors­ten Mäger (Anti­trust, Düssel­dorf), Coun­sel Dr. Gunther Wagner (Tax, Munich) as well as asso­cia­tes Dr. Achim Speng­ler, Dr. Vero­nika Wimmer, Dr. Sebas­tian Siller, Dr. Johan­nes Baumann (all Corporate/M&A, Munich), Till Hiemenz-Muel­ler, Fran­ziska Dechamps (both Finan­cing, Frank­furt), Dr. Marius Mayer (Frank­furt), Vicki Treib­mann (Düssel­dorf) (both Labor Law), Dr. Anja Balitzki, Laura Delgado Pazos (both Anti­trust, Düssel­dorf), Dr. Matthias Roth­kopf (Intellec­tual Property/IT) and Dr. Norman Koschmie­der (Public Commer­cial Law) (both Düsseldorf).

News

Munich / Frank­furt am Main — Munich-based tele­me­di­cine company Tele­Cli­nic has successfully closed its Series A finan­cing and recei­ved a capi­tal commit­ment of seven million euros from Idin­vest Part­ners to expand its market leader­ship in telemedicine.

Idin­vest Part­ners is a Euro­pean invest­ment company specia­li­zing in the SME segment, with more than eight billion euros in assets under manage­ment, which has alre­ady comple­ted more than 4,000 finan­cings throug­hout Europe. As one of the largest Euro­pean venture capi­tal inves­tors, Idin­vest Part­ners is able to support port­fo­lio compa­nies from seed finan­cing to later finan­cing stages. The company has previously funded digi­tal pioneers such as Allt­hings, Deezer, Wefox and Withings.

Just in Novem­ber 2017, Tele­Cli­nic had closed a seed finan­cing of two million euros. Now the next big step is about to be taken to scale the busi­ness model and provide digi­tal access to medi­cal care for milli­ons more pati­ents. New stra­te­gic part­ner­ships and marke­ting measu­res are plan­ned for this purpose.

Today, 50 percent of all private pati­ents in Germany alre­ady have free digi­tal access to doctors from 30 special­ties thanks to Tele­Cli­nic. The number of people with statu­tory health insu­rance is around nine million. This makes Tele­Cli­nic part of stan­dard care. For private pati­ents, e‑prescriptions are possi­ble throug­hout Germany via Tele­Cli­nic. For this purpose, the company coope­ra­tes with 7,000 phar­macies. Those with statu­tory health insu­rance are to follow suit in 2019 — initi­ally as part of a pilot project. Medi­cal services are available seven days a week, around the clock, and on holidays.

With annual growth of 3.8 percent, the health­care sector is growing signi­fi­cantly faster than the gross dome­stic product (source: BMWI Gesund­heits­wirt­schaft Zahlen und Fakten 2016). The health­care indus­try is thus a growth sector that is not depen­dent on econo­mic cycles. The private sector, for exam­ple medi­cal products or e‑health appli­ca­ti­ons, accounts for 21.3 percent of value added. Tele­me­di­cine is seen as a promi­sing future market.

Katha­rina Jünger (photo) , CEO of Tele­Cli­nicis convin­ced that tele­me­di­cine will play a central role in the German health­care system in the future: “The digi­tiza­tion of the health­care system is curr­ently advan­cing in leaps and bounds. We are actively helping to shape this deve­lo­p­ment and want to use Tele­Cli­nic to ensure digi­tal access to high-quality primary care across the coun­try. Germany needs tele­me­di­cine to effi­ci­ently meet chal­lenges such as demo­gra­phic change. People are getting older and, as a result, spen­ding is rising. Tele­con­sul­ta­tion alone has an esti­ma­ted bene­fit poten­tial of 4.4 billion euros. We are plea­sed to have gained a strong part­ner in Idin­vest Part­ners to digi­tally shape the future of health.”

Matthieu Baret, Mana­ging Part­ner at Idin­vest Part­ners and respon­si­ble for Venture and Growth Capi­tal, said: “Idin­vest Part­ners has made a name for itself as one of the highest-profile venture capi­tal inves­tors in Europe with invest­ments in well-known and successful compa­nies in the digi­tal and health­care indus­tries. The invest­ment in Tele­Cli­nic repres­ents another mile­stone in this stra­tegy. Tele­Cli­nic is a pioneer in a promi­sing busi­ness area and a market with great poten­tial. In an envi­ron­ment of demo­gra­phic change and incre­asing gaps in medi­cal care in rural areas, the company fulfills an important social mission. We are plea­sed to support Tele­Cli­nic in fulfil­ling this mission.”

About Tele­Cli­nic
Tele­Cli­nic is a digi­tal health plat­form and first point of cont­act for people who have ques­ti­ons about their health. The Tele­Cli­nic physi­ci­ans are available for pati­ents seven days a week and at any time of day — without long waiting times. Only physi­ci­ans with a German license to prac­tice medi­cine are admit­ted to Tele­Cli­nic. Medi­cal consul­ta­tion takes place via modern and nowa­days common commu­ni­ca­tion chan­nels. The pati­ent can choose whether the doctor’s conver­sa­tion takes place via video chat or on the phone, for exam­ple. Tele­Cli­nic is also a digi­tal pioneer in the area of e‑prescription: e‑prescriptions have been possi­ble for priva­tely insu­red pati­ents since the begin­ning of 2018. To this end, the company coope­ra­tes with 7,000 phar­macies in private prac­tice. To ensure that pati­ents can use the services of the Tele­Cli­nic free of charge, the company coope­ra­tes with various payers. Curr­ently, eight private health insu­r­ers and four statu­tory health insu­r­ers coope­rate with Tele­Cli­nic. In addi­tion, as part of the coope­ra­tion with the Asso­cia­tion of Statu­tory Health Insu­rance Physi­ci­ans in Baden-Würt­tem­berg, all statu­tory health insu­rance funds in Baden-Würt­tem­berg bear the costs for digi­tal health services via the Tele­Cli­nic infrastructure.

Data secu­rity is a top prio­rity: the Tele­Cli­nic app ther­e­fore complies with the requi­re­ments of the Medi­cal Devices Act for CE certi­fi­ca­tion. TeleClinic’s mission is to deve­lop digi­tal and effi­ci­ent alter­na­ti­ves for the German health­care system that bene­fit pati­ents, insu­rance compa­nies, health insu­r­ers and doctors. www.teleclinic.com

About Idin­vest Partners
Idin­vest Part­ners is a leading Euro­pean invest­ment firm focu­sed on the mid market. Curr­ently, Idin­vest Part­ners mana­ges assets of around €8 billion with more than 90 employees and has offices in Paris, Frank­furt, Madrid, Shang­hai and Dubai. The company has three busi­ness units: Venture & Growth Capi­tal, Private Debt and Private Funds Group. The company was foun­ded in 1997 as part of the Alli­anz Group and has been inde­pen­dent since 2010. In Janu­ary 2018, Idin­vest Part­ners merged with Eura­zeo. The merger has crea­ted a leading invest­ment company in Europe and North America with 15 billion euros in assets under management.

News

Hamburg — Fiel­mann Ventures GmbH, a wholly owned subsi­diary of Fiel­mann A, has acqui­red around 20 per cent of the shares in augmen­ted reality specia­list Fitting­Box S.A. as part of a capi­tal increase. The stra­te­gic invest­ment in the French tech­no­logy company is a consis­tent step in Fielmann’s digi­tiza­tion stra­tegy. The parties have agreed not to disc­lose the exact purchase price.

Marc Fiel­mann (photo), Chair­man of the Manage­ment Board of Fiel­mann AG: “With 13 patents, Fitting­Box is the world leader in the field of 3D fitting of glas­ses and sunglas­ses. With this invest­ment, we are deepe­ning our stra­te­gic coope­ra­tion. Toge­ther we are working on the online purchase of glas­ses in Fiel­mann quality. This requi­res inno­va­tive tech­no­lo­gies such as
the 3D try-on, but also the milli­me­ter-precise 3D fitting of glas­ses. This is how Fiel­mann is digi­tiz­ing the opti­cal indus­try to the bene­fit of custo­mers without compro­mi­sing on quality.”

Thomas Rützel, Mana­ging Direc­tor of Fiel­mann Ventures GmbH: “Our invest­ment in Fitting­Box is the result of a detailed analy­sis. Fitting­Box has deve­lo­ped a 3D fitting tech­no­logy that is clearly supe­rior to all rele­vant alter­na­ti­ves. This tech­no­logy is a key compo­nent in the digi­tal plat­form that Fiel­mann Ventures is deve­lo­ping with part­ners for the opti­cal industry.”

Benja­min Hakoun, Mana­ging Direc­tor and co-foun­der Fitting­Box S.A.: “We are thril­led to have Fiel­mann, one of the world’s leading opti­cal compa­nies, as our stra­te­gic part­ner. Thanks to the invest­ment, we can deve­lop our tech­no­logy solu­ti­ons even faster and open up new sales markets.
Our two compa­nies are united by a strictly custo­mer-orien­ted corpo­rate culture. Toge­ther, we will further expand FittingBox’s posi­tion as the leading tech­no­logy solu­tion for omnich­an­nel eyewear purcha­sing, accom­pany­ing the wearer throug­hout the entire custo­mer jour­ney, online and in-store. We are very plea­sed to have Squair Law as our legal advi­sor and CapM Advi­sors as our finan­cial advi­sor in closing this investment.
have supported.”

Ariel Chou­kroun, CTO and co-foun­der Fitting­Box S.A.: “Fiel­mann has deca­des of expe­ri­ence, knows the needs of spec­ta­cle wearers like no other company. This puts Fitting­Box in a posi­tion to align our tech­no­logy solu­ti­ons even better with the wishes of the custo­mers. On the one hand, spec­ta­cle wearers bene­fit from this, and on the other hand, of course, our custo­mers, i.e. retail­ers and manu­fac­tu­r­ers, also bene­fit. Kreaxi and LBO France remain share­hol­ders in Fitting­Box. They have enab­led the growth of our company with their early investments.”

In the next few weeks, Fiel­mann will inte­grate the 3D fitting into the new omnich­an­nel consul­ting process
in the test market Austria, is test­ing the solu­tion both in its bran­ches and online. The roll­out of the new system in Germany will follow in 2019.

About Fiel­mann Ventures GmbH
Fiel­mann Ventures GmbH was foun­ded in August 2012 as an inde­pen­dent subsi­diary of Fiel­mann AG based in Hamburg. Fiel­mann Ventures deve­lops and promo­tes products, tech­no­lo­gies and sustainable busi­ness models for the future of the opti­cal industry.

About Fiel­mann AG
Fiel­mann stands for eyewear fashion at a fair price, opera­tes over 700 bran­ches across Europe. 24 million people wear glas­ses from Fiel­mann; in Germany, the listed family company sells every second pair of glas­ses. Fiel­mann covers all levels of value crea­tion in optics, is a desi­gner, manu­fac­tu­rer and optician.

About Fitting­Box S.A.
Foun­ded in 2006, Fitting­Box (www.fittingbox.com) is the world’s leading provi­der of augmen­ted reality tech­no­logy such as 3D try-on for eyeglas­ses and sunglas­ses. The company is head­quar­te­red in Toulouse, France, and also opera­tes a sales company in Miami, USA. Fitting­Box deve­lops inno­va­tive tech­no­logy solu­ti­ons and digi­tal content for the opti­cal indus­try, has the world’s largest data­base of frame photos and 3D models. In the more than 10-year history of the company, Fitting­Box has alre­ady recei­ved nume­rous awards and prizes in the field of rese­arch and innovation.

News

Landshut/Würzburg — Bayern Kapi­tal is taking a first-time stake in TNI medi­cal AG (TNI medi­cal) from Würz­burg with its EFRE inno­va­tion fund as part of a new finan­cing round. The company deve­lops, manu­fac­tures and sells devices for venti­la­tion therapy in pati­ents with the so-called respi­ra­tory distress syndrome. This syndrome includes COPD, a chro­nic obstruc­tive pulmo­nary dise­ase that is the fourth leading cause of death globally, accor­ding to the World Health Orga­niza­tion (WHO). Another new inves­tor is the invest­ment company GMH-Ventures GmbH. The exis­ting inves­tors SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment mbH (SHS), Kredit­an­stalt für Wieder­auf­bau(KfW) and Pathena Sicar are also parti­ci­pa­ting in this round. TNI medi­cal intends to use the funds for the further deve­lo­p­ment and world­wide appr­oval of the products as well as for the deve­lo­p­ment of further markets, espe­ci­ally in non-Euro­pean count­ries such as the USA and China.

TNI medi­cal AG, head­quar­te­red in Würz­burg, Germany, was foun­ded about ten years ago as a spin-off of seleon GmbH, an engi­nee­ring service provi­der in the medi­cal tech­no­logy sector. Imme­dia­tely after the spin-off, the company star­ted deve­lo­ping the TNI soft­Flow high-flow venti­la­tor. Another main­stay from the very begin­ning was the trade in diagno­stic and thera­peu­tic products. Follo­wing successful clini­cal trials of the venti­la­tors, SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment mbH (SHS) and Kredit­an­stalt für Wieder­auf­bau (KfW) took a stake in the company in 2010. TNI medi­cal used the funds to further deve­lop the product family.

Pati­ents receive a warm, moist airflow directly into the nose without conden­sa­tion through a thin, heated and noise-opti­mi­zed nasal cannula with the venti­la­tors from the TNI soft­Flow family. The flow rate of the air as well as the humi­dity can be precis­ely adjus­ted and oxygen can be added if neces­sary. This leads to effec­tive treat­ment of pati­ents. In addi­tion, the products are uncom­pli­ca­ted to use, the nasal cannula is easy to put on or take off. In contrast, with many conven­tio­nal venti­la­tors with closed nasal and face masks, pati­ents complain of limi­ted comfort. When trea­ted with TNI venti­la­tors, the pati­ent can conti­nue to do simple things during therapy, such as eating, drin­king, talking, or taking medi­ca­ti­ons. TNI medical’s novel therapy not only achie­ves very good clini­cal results, but also means better tole­r­a­bi­lity for pati­ents compared to tradi­tio­nal mask therapy. TNI medi­cal products are suita­ble for use in clinics as well as at home.

The Bayern Kapi­tal Inno­va­ti­ons­fonds EFRE (BKE) is funded by the Euro­pean Union from the Euro­pean Regio­nal Deve­lo­p­ment Fund (ERDF). BKE prima­rily finan­ces inno­va­tive tech­no­logy compa­nies that are loca­ted outside the Munich metro­po­li­tan area and want to use BKE’s equity capi­tal to deve­lop new products and produc­tion proces­ses and launch and pene­trate them on the market.

Dr. Georg Ried (photo), Mana­ging Direc­tor of Bayern Kapi­tal, says: “TNI medi­cal has deve­lo­ped an outstan­ding tech­no­logy that can help many people around the world. In doing so, the team at TNI medi­cal has consis­t­ently thought of the product from the patient’s point of view. In addi­tion to the good econo­mic deve­lo­p­ment, this aspect convin­ced us to invest in TNI medical.”

Rein­hilde Spat­scheck, Chair­wo­man of the Super­vi­sory Board of TNI medi­cal AG and Mana­ging Direc­tor and Part­ner at SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment, says: “TNI medi­cal AG has achie­ved signi­fi­cant mile­sto­nes in the deve­lo­p­ment, appr­oval and clini­cal test­ing of the TNI soft­Flow family in recent years. After achie­ving CE and FDA appr­oval and soon hopefully CFDA appr­oval, the time has come to consis­t­ently deve­lop the very large market poten­tial world­wide with the funds from the new finan­cing round — both in clinics and in the home­care sector.”

About TNI Medi­cal AG
TNI Medi­cal AG deve­lops, manu­fac­tures and distri­bu­tes devices for respi­ra­tory therapy in pati­ents with respi­ra­tory distress syndrome, such as chro­nic obstruc­tive pulmo­nary dise­ase (COPD). For more than ten years, the Würz­burg-based company has stood for exactly one goal: to consis­t­ently deve­lop nasal high-flow therapy in order to offer respi­ra­tory insuf­fi­ci­ency pati­ents respi­ra­tory support with maxi­mum effi­ci­ency and comfort. Based on inten­sive rese­arch and reali­zed through precise deve­lo­p­ment work in nasal insuf­fla­tion therapy (TNI), the TNI soft­Flow system gene­ra­tion offers the highest therapy quality for all age groups in the clinic as well as in homecare.

About Bayern Kapital
Bayern Kapi­tal GmbH, based in Lands­hut, was foun­ded in 1995 as a wholly owned subsi­diary of LfA Förder­bank Bayern on the initia­tive of the Bava­rian state govern­ment. As the venture capi­tal company of the Free State of Bava­ria, Bayern Kapi­tal provi­des equity capi­tal to the foun­ders of inno­va­tive high-tech compa­nies and young, inno­va­tive tech­no­logy compa­nies in Bava­ria. Bayern Kapi­tal curr­ently mana­ges eleven invest­ment funds with an invest­ment volume of around 325 million euros. To date, Bayern Kapi­tal has inves­ted around 285 million euros of venture capi­tal in some 265 inno­va­tive tech­no­logy-orien­ted compa­nies from a wide range of sectors, inclu­ding life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. As a result, more than 5,000 jobs have been perma­nently crea­ted in Bava­ria in sustainable compa­nies. www.bayernkapital.de

News

Munich — Hofmann & Stir­ner Zuführ­sys­teme GmbH is recei­ving around €1 million to expand its digi­tal tech­no­lo­gies in the field of feeding tech­no­logy. High-Tech Grün­der­fonds and a busi­ness angel are parti­ci­pa­ting as inves­tors. The finan­cing round was broke­red by the BayStartUP inves­tor network. Hofmann & Stir­ner deve­lops feeding systems with the help of digi­tal twins using compu­ter aided design (CAD) and the simu­la­tion of produc­tion plants. They thus master the syste­ma­tic and sorted feeding of a large quan­tity of very small compon­ents into the manu­fac­tu­ring process of indus­trial products. Hofmann & Stirner’s vision is the auto­ma­tic deve­lo­p­ment of any feeding system by means of arti­fi­cial intel­li­gence. With the seed finan­cing, Hofmann & Stir­ner aims to achieve further mile­sto­nes in tech­no­logy development.

Feeding systems are smal­ler indus­trial systems that feed small parts such as screws, etc. to larger manu­fac­tu­ring machi­nes. They ensure that compon­ents of a product are available at the right assem­bly point at the opti­mum time and in sorted form so that the corre­spon­ding products can be manu­fac­tu­red. They can be found in manu­fac­tu­ring proces­ses in indus­tries ranging from auto­mo­tive to elec­tro­nics. Up to now, these feeding systems have been manu­fac­tu­red almost exclu­si­vely in trial-and-error proces­ses by expe­ri­en­ced sheet metal workers with the aid of sample compon­ents. Hofman & Stirner’s tech­no­logy digi­ti­zes this process. To achieve this, the company relies on a holi­stic approach consis­ting of the inno­va­tive ROTU machine archi­tec­ture and its own soft­ware tail­o­red to it. Seve­ral soft­ware modu­les interlock and map all rele­vant physi­cal proces­ses in the feeding system.

Each real ROTU thus emer­ges via its digi­tal image, expan­ding the trai­ning data­base for arti­fi­cial neural network lear­ning to fully auto­mate the deve­lo­p­ment of new ROTUs. The data­base forms the basis for lear­ning arti­fi­cial neural networks and helps to conti­nuously deve­lop the system. The goal is to obtain new ROTU systems for various mate­ri­als to be conveyed in a fully auto­ma­ted manner. “Anyone who only uses off-the-shelf soft­ware will fail in mecha­ni­cal engi­nee­ring due to digi­tiza­tion,” says Daniel Hofmann, CEO and co-foun­der of Hofmann & Stir­ner Zuführ­sys­teme GmbH. Hofmann & Stirner’s solu­tion designs the feeding system so that users can convert it to convey a comple­tely new mate­rial in less than 2 minutes.

About BayStartUP
BayStartUP is the Bava­rian startup network for foun­ders, inves­tors and compa­nies. With the Bava­rian Busi­ness Plan Compe­ti­ti­ons, an exten­sive coaching offer and Germany’s largest inves­tor network, it supports start­ups in opti­mi­zing their stra­tegy, buil­ding their busi­ness and finding start-up or growth capi­tal. For private and insti­tu­tio­nal inves­tors, BayStartUP ensu­res a quali­fied deal flow and offers startup insights at exclu­sive busi­ness angel meetings and inves­tor confe­ren­ces. With nati­on­wide startup indus­try matchings and concep­tual offers, BayStartUP advi­ses estab­lished compa­nies on the deve­lo­p­ment of suita­ble stra­te­gies for coope­ra­tion with start­ups. Through BayStartUP, foun­ders have cont­act oppor­tu­ni­ties with more than 280 listed busi­ness angels, over 100 insti­tu­tio­nal inves­tors and finan­cing from €50,000 to €6 million. Each year, BayStartUP’s inves­tor network brokers around €50 million to start­ups, espe­ci­ally in the early stages. So far, more than 1,600 compa­nies have emer­ged from the Bava­rian Busi­ness Plan Compe­ti­ti­ons. Today, they are active on the market with appro­xi­m­ately 11,400 employees and gene­rate sales of around 1 billion euros. They have about 400 parti­ci­pant teams each year.

News

Stutt­gart — Stutt­gart-based invest­ment company Finexx has star­ted inves­t­ing from its first fund closed in mid-Novem­ber 2018. In 2017, Finexx had alre­ady acqui­red mino­rity shares in the welding specia­list WIDOSas a co-part­ner of the Hanno­ver Finanz Group, and now the first majo­rity share­hol­ding has been reali­zed with GSE Vertrieb Biolo­gi­sche Nahrungs­er­gän­zung & Heil­mit­tel GmbH from Saar­brü­cken. The tran­sac­tion, which has alre­ady been comple­ted, took place as part of a succes­sion plan: The seller of the shares is foun­der and mana­ging direc­tor Michael Gracher; the two other mana­ging direc­tors remain on board and conti­nue to be among the share­hol­ders. GSE has been on the market since 1994 and deve­lops and distri­bu­tes food supple­ments on an orga­nic certi­fied basis through natu­ral food retailers.

The volume of Finexx Fund I is 35 million euros, most of which comes from insti­tu­tio­nal inves­tors such as insu­rance compa­nies and pension funds. Invest­ments are made across all sectors in small and medium-sized enter­pri­ses (SMEs) with sales of 10 million euros or more. Further prere­qui­si­tes are sustainable earning power and cash flow based on a successful busi­ness model as well as a quali­fied manage­ment team. Finexx commits five to 20 million euros of equity capi­tal in each case.

Finexx Mana­ging Direc­tor Matthias Heining: “GSE is excel­lently posi­tio­ned in the market. Toge­ther with the accom­plished manage­ment and dedi­ca­ted employees, we now want to move to the next stage of deve­lo­p­ment — this includes an expan­sion of product deve­lo­p­ment, sales, inter­na­tio­na­liza­tion and online busi­ness. We see excel­lent future pros­pects for GSE in view of incre­asingly health-conscious and orga­nic-orien­ted consumers.”

Such a growth stra­tegy is in line with Finexx’s invest­ment philo­so­phy: “In addi­tion to long-term orien­ted, relia­ble busi­ness models, we are prima­rily concer­ned with profes­sio­nal further deve­lo­p­ment,” explains Dr. Markus Seiler, also Mana­ging Direc­tor of Finexx. “We see oursel­ves as an insti­tu­tio­nal family share­hol­der who speaks the language of family-run compa­nies and who brings indus­try expe­ri­ence, user know­ledge and an excel­lent network to the table without inter­fe­ring in day-to-day opera­ti­ons.” Dr. Seiler, for exam­ple, has many years of expe­ri­ence as a mana­ging direc­tor in family-owned and group compa­nies in the indus­trial and tech­no­logy sectors (inclu­ding GEA Group and Brand Group); Heining was mana­ging direc­tor of the renow­ned invest­ment company BWK in Stutt­gart and in various family-owned compa­nies for seve­ral years. Toge­ther, they combine 30 years of tech­ni­cal and commer­cial exper­tise and can point to signi­fi­cant succes­ses. “In the current envi­ron­ment, we still see a lot of poten­tial and need to support exci­ting compa­nies and successful entre­pre­neurs with drive — we expect to see more tran­sac­tions,” Heining said.

About Finexx
Finexx GmbH Unter­neh­mens­be­tei­li­gun­gen, based in Stutt­gart, is a consul­ting company foun­ded in 2013 that specia­li­zes in estab­lished medium-sized compa­nies. Typi­cal fields of acti­vity are growth and acqui­si­tion finan­cing as well as the support of chan­ges in the share­hol­der struc­ture and succes­sion planning.

Finexx invests long-term funds (equity capi­tal of between 5 and 50 million euros), mainly in the form of majo­rity share­hol­dings, in compa­nies from the German-spea­king region, inclu­ding insu­rance compa­nies and pension funds. These have sales of EUR 10 million or more, a quali­fied manage­ment team, and can demons­trate sustainable earnings power and cash flow based on a successful busi­ness model.

The team has many years of indus­trial and manage­ment expe­ri­ence as well as profound know-how in the invest­ment sector — both are brought to bear for the successful further deve­lo­p­ment of compa­nies and in the asso­cia­ted change proces­ses. Finexx supports manage­ment by provi­ding active commer­cial and tech­ni­cal advice without inter­fe­ring with day-to-day opera­ti­ons, as well as a cross-indus­try network. www.finexx.de

News

Munich, London — Gareth Whiley (pictu­red) will take over the role of Mana­ging Part­ner at Silver­fleet Capi­tal from Neil MacDou­gall on April 1, 2019, when he will become Chair­man of the Euro­pean private equity firm specia­li­zing in “buy to build.” In this new role, MacDou­gall will remain a member of the invest­ment commit­tee of Silver­fleet Capital’s funds; MacDou­gall will also serve in an advi­sory capa­city to the 15 part­ners in the London, Munich, Paris and Stock­holm offices.

Neil MacDou­gall joined Silver­fleet Capi­tal in 1989 and has been a Mana­ging Part­ner since 2004. In 2007, he led the buy-out of Silver­fleet Capi­tal (then “PPM Capi­tal”) from the insu­rance group Pruden­tial plc. For 14 years, he headed Silver­fleet Capi­tal as Mana­ging Part­ner. Under his aegis, Silver­fleet deve­lo­ped into one of the leading Euro­pean private equity houses in the mid-market segment. Gareth Whiley joined the firm in 1997, became a part­ner in 2002 and was respon­si­ble for a number of successful invest­ments in Europe. Most recently, he led the invest­ment acti­vi­ties in the UK and Scan­di­na­via as well as in the consu­mer goods sector.

Silver­fleet Capi­tal prepa­res for next phase of growth with leader­ship change. Curr­ently, the 30-strong invest­ment team mana­ges more than 1.2 billion euros; the invest­ments, based in the UK, Ireland, the DACH region, France, the Bene­lux count­ries and Scan­di­na­via, each have an enter­prise value of between 20 and 300 million euros. In the future, Silver­fleet Capi­tal will conti­nue to pursue its 30-year proven invest­ment stra­tegy — the focus will remain on buil­ding inter­na­tio­nal market-leading companies.

“I am proud to have been able to lead Silver­fleet for many years and to have been actively invol­ved in its growth,” explains Neil MacDou­gall. “The change in leader­ship was inten­si­vely prepared and also agreed with our inves­tors. Gareth Whiley has played an important role in Silverfleet’s success over the past 20 years and his appoint­ment as Mana­ging Part­ner is the logi­cal step — I look forward to conti­nuing to work closely with him.” Gareth Whiley adds, “It is a parti­cu­lar honor to be given respon­si­bi­lity for such an outstan­ding team and the joint deve­lo­p­ment of the company. Neil MacDou­gall has made an outstan­ding contri­bu­tion — I’m deligh­ted that he will conti­nue to guide the further expan­sion of our platform.”

About Silver­fleet Capital
Silver­fleet Capi­tal has been active as a private equity inves­tor in the Euro­pean mid-market for more than 30 years and curr­ently mana­ges around €1.2 billion with its 30-strong invest­ment team in Munich, London, Paris, Stock­holm and Amsterdam.

Eight invest­ments have alre­ady been made from the second inde­pen­dent fund closed in 2015 with a volume of 870 million euros: The Masai Clot­hing Company, a whole­sa­ler and retailer of women’s fashion head­quar­te­red in Denmark; Coven­tya, a French deve­lo­per of specialty chemi­cals; Sigma Compon­ents, a British manu­fac­tu­rer of precis­ion compon­ents for civil avia­tion; Life­time Trai­ning, a UK provi­der of trai­ning programs; Pumpen­fa­brik Wangen, a manu­fac­tu­rer of specialty pumps based in Germany; Riviera Travel, a British opera­tor of escor­ted group tours and crui­ses; 7days, a West­pha­lian supplier of medi­cal work­wear; and Prefere Resins, a leading phen­o­lic and amino resin produ­cer in Europe.

Silver­fleet achie­ves value growth through its “buy to build” invest­ment stra­tegy. As part of this stra­tegy, Silver­fleet is acce­le­ra­ting the growth of its subsi­dia­ries by inves­t­ing in new products, produc­tion capa­city and employees, instal­ling successful retail formats or making follow-up acqui­si­ti­ons. Since 2004, Silver­fleet Capi­tal has inves­ted €1.9 billion in 28 companies.

Silver­fleet specia­li­zes in four key indus­tries: Busi­ness and Finan­cial Services, Health­care, Manu­fac­tu­ring, and Retail and Consu­mer Goods. Since 2004, the private equity inves­tor has inves­ted 33 percent of its assets in compa­nies head­quar­te­red in the DACH region, 31 percent in the UK and Ireland, 19 percent in Scan­di­na­via and 17 percent mainly in France and the Bene­lux count­ries (1).

Silver­fleet Capi­tal has a solid invest­ment track record. Most recently, Silver­fleet sold Ipes, a leading provi­der of outsour­cing services to Euro­pean private equity firms (invest­ment multi­ple 3.8x); CCC, one of the leading BPO services provi­ders in Europe, as well as Cimbria, a Danish manu­fac­tu­rer of agri­cul­tu­ral equip­ment (2); Kalle, a German manu­fac­tu­rer of arti­fi­cial sausage pellets (invest­ment multi­ple 3.5x); OFFICE, a UK foot­wear retailer (invest­ment multi­ple 3.4x); and Aesica, a leading phar­maceu­ti­cal CDMO company (invest­ment multi­ple 3.3x).

News

Large success for KMU inte­rest fede­ra­tion / BMF pres­ents draft bill for the change of the folder right.
The merger of the capi­tal market-orien­ted SME sector is paying off. In Septem­ber, the Capi­tal Market SME Inte­rest Group submit­ted a peti­tion to amend the pros­pec­tus law to the Fede­ral Minis­try of Finance (BMF). 100 capi­tal market-orien­ted compa­nies supported the peti­tion. The BMF has now reac­ted at short notice to the criti­cism from SMEs and presen­ted a draft bill for a new law. Main content: Pros­pec­tus-free rights issues of up to EUR 8 million will be possible.

The Act on the Exer­cise of Opti­ons under the EU Pros­pec­tus Regu­la­tion and on the Adapt­a­tion of Other Finan­cial Market Laws, which came into force on July 21, 2018 and, among other things, provi­des for pros­pec­tus-free public offe­rings of up to EUR 8 million, preven­ted pros­pec­tus-free rights capi­tal increa­ses by regu­la­ting indi­vi­dual invest­ment thres­holds for non-quali­fied inves­tors. The indi­vi­dual invest­ment thres­holds were not aligned with the subscrip­tion rights of exis­ting share­hol­ders in the event of capi­tal increa­ses under the German Stock Corpo­ra­tion Act (AktG). The now presen­ted draft bill of a law on the further imple­men­ta­tion of the EU Pros­pec­tus Regu­la­tion and on the amend­ment of finan­cial market laws of Novem­ber 12, 2018 provi­des that the indi­vi­dual invest­ment thres­holds do not apply to secu­ri­ties offe­red to exis­ting share­hol­ders in the context of a rights issue.

“It is a great success for our still young asso­cia­tion that we succee­ded in chan­ging the law and uniting the inte­rests of the capi­tal market-orien­ted SMEs. There has never been such a peti­tion and an asso­cia­tion of capi­tal market-orien­ted SMEs in this form before. The success proves us right in our efforts,” says Ingo Wege­rich (photo), Presi­dent of the Asso­cia­tion and Part­ner at Luther Rechtsanwaltsgesellschaft.

About the Inter­es­sen­ver­band kapi­tal­markt­ori­en­tier­ter klei­ner und Mitte­ler Unter­neh­men e.V.
Foun­ded on August 30, 2017 and head­quar­te­red in Frank­furt am Main, the asso­cia­tion is parti­cu­larly commit­ted to impro­ving the rele­vant frame­work condi­ti­ons for small and medium-sized enter­pri­ses in capi­tal market finan­cing and actively advo­ca­tes the inte­rests of capi­tal market-orien­ted SMEs in dialog with poli­cy­ma­kers, legis­la­tive bodies, super­vi­sory autho­ri­ties, capi­tal market insti­tu­ti­ons, inte­rest groups and the gene­ral public. Members are SMEs, service provi­ders, finan­cial insti­tu­ti­ons and the media. The Manage­ment Board includes Ingo Wege­rich (Luther Rechts­an­walts­ge­sell­schaft), Alex­an­der Starke, Nils Manegold (max 21 AG), Alex­an­der Deuss (mwb fair­trade) and Thomas Stewens (BankM).

Inter­es­sen­ver­band kapi­tal­markt­ori­en­tier­ter klei­ner und mitt­le­rer Unter­neh­men e.V.

News

Munich/Jena — mi2-factory GmbH closes a finan­cing round and raises fresh capi­tal in the upper 6‑digit range. The exis­ting lead inves­tor bm|t GmbH (Betei­li­gungs­ma­nage­ment Thürin­gen) and three busi­ness angels from the Munich region are parti­ci­pa­ting as inves­tors. With the unique manu­fac­tu­ring tech­no­logy, the so-called energy filter tech­no­logy, of the mi2-factory, power micro­chip produ­cers can manu­fac­ture their chips in an opti­mi­zed way or create new types of chips.

The unique selling point of the mi2-factory is the highly defi­ned proces­sing of the base mate­rial of power micro­chips, which leads to cost and perfor­mance advan­ta­ges for custo­mers and enables comple­tely new types of chips. These chips are made of the highly effi­ci­ent mate­rial sili­con carbide and are manu­fac­tu­red by mi2-factory’s custo­mers to be used in parti­cu­lar in target appli­ca­ti­ons for rege­ne­ra­tive energy appli­ca­ti­ons (e.g. photo­vol­taics, elec­tro­mo­bi­lity, wind power).

mi2-factory plans to invest the capi­tal raised in the further deve­lo­p­ment of product and manu­fac­tu­ring tech­no­logy. The current finan­cing round also came about with support from the BayStartUP inves­tor network. “The profes­sio­nal support in the finan­cing process by BayStartUP was outstan­ding. At the Munich BayStartUP Venture Confe­rence in March, mi2-factory convin­ced me of its busi­ness idea,” says Fried­rich Hecker, one of the private inves­tors.

After the mi2 team got in touch with the inves­tors of the 1st finan­cing round at the Inves­tor Days Thurin­gia, this time the startup addi­tio­nally sought inves­tors inter­na­tio­nally — among others also in China. “Ulti­m­ately, the rela­ti­onship of trust that we have deve­lo­ped with our inves­tors, the terms and condi­ti­ons, and the time hori­zon were key factors in our decis­ion,” says Benja­min Tom, busi­ness manage­ment direc­tor and co-foun­der of mi2-factory.

Poten­tial for basic technology
“So far, our biggest chall­enge has been to initiate compre­hen­sive custo­mer projects for forward-looking appli­ca­ti­ons. Our next mile­stone will be the conclu­sion of deve­lo­p­ment coope­ra­ti­ons. In these, we want to estab­lish the energy filter tech­no­logy on the market as a basic manu­fac­tu­ring tech­no­logy for the produc­tion of the next gene­ra­tion of power micro­chips,” reports Florian Krip­pen­dorf, tech­ni­cal mana­ging direc­tor and co-foun­der of mi2-factory.

The mate­rial sili­con carbide will gain great importance in the coming years, espe­ci­ally for micro­chips with high voltage clas­ses. “Due to the lower power losses of sili­con carbide compared to conven­tio­nal sili­con, sili­con carbide micro­chips are needed in power lines, trains, elec­tric cars, char­ging stati­ons, photo­vol­taic and wind power plants,” explains Prof. Dr. Michael Rüb, stra­te­gist and co-foun­der of mi2-factory. “In addi­tion to the advan­tage that sili­con carbide chips are charac­te­ri­zed by signi­fi­cantly lower losses than conven­tio­nal sili­con-based chips, they also enable signi­fi­cantly smal­ler modu­les and systems to be built than is possi­ble with sili­con. This redu­ces the volume and weight of power converters.”

About BayStartUP
BayStartUP is the Bava­rian startup network for foun­ders, inves­tors and compa­nies. With the Bava­rian Busi­ness Plan Compe­ti­ti­ons, an exten­sive coaching offer and Germany’s largest inves­tor network, it supports start­ups in opti­mi­zing their stra­tegy, buil­ding their busi­ness and finding start-up or growth capi­tal. For private and insti­tu­tio­nal inves­tors, BayStartUP ensu­res a quali­fied deal flow and offers startup insights at exclu­sive busi­ness angel meetings and inves­tor confe­ren­ces. With nati­on­wide startup indus­try matchings and concep­tual offers, BayStartUP advi­ses estab­lished compa­nies on the deve­lo­p­ment of suita­ble stra­te­gies for coope­ra­tion with start­ups. Through BayStartUP, foun­ders have cont­act oppor­tu­ni­ties with more than 280 listed busi­ness angels, over 100 insti­tu­tio­nal inves­tors and finan­cing from €50,000 to €6 million. Each year, BayStartUP’s inves­tor network brokers around €50 million to start­ups, espe­ci­ally in the early stages. www.baystartup.de

About mi2-factory GmbH
mi2-factory GmbH is a start-up from Jena (Thurin­gia) in the semi­con­duc­tor sector foun­ded in 2016. Core compe­tence is the deve­lo­p­ment and distri­bu­tion of the so-called energy filter tech­no­logy — a manu­fac­tu­ring tech­no­logy for the proces­sing of the micro­chip base mate­rial sili­con carbide. mi2-factory’s proprie­tary energy filter tech­no­logy redu­ces costs, increa­ses perfor­mance and enables design inno­va­tion for high-effi­ci­ency wind power, photo­vol­taics and elec­tric mobi­lity. Custo­mers of mi2-factory are well-known corpo­ra­ti­ons from Europe, Japan and the USA, which produce power semi­con­duc­tor compon­ents in high quan­ti­ties. www.mi2-factory.com

About bm|t GmbH
bm‑t betei­li­gungs­ma­nage­ment thürin­gen gmbh is the manage­ment company for curr­ently eight invest­ment funds. As a univer­sal invest­ment company for Thurin­gia, bm‑t invests in all high-yield sectors and in every phase of life of compa­nies with a promi­sing busi­ness model, from start-up to prepa­ra­tion for IPO or MBO/MBI. The bm‑t is a finan­cial inves­tor, which focu­ses on entre­pre­neu­rial types and foun­ders and actively supports them. The bm‑t combi­nes invest­ment and active support through busi­ness consul­ting, struc­tu­ring of finan­cing concepts, and parti­ci­pa­tion in commit­tees of the compa­nies. With a strong network, bm‑t supports its busi­ness part­ners as a coach and spar­ring part­ner. www.bm‑t.de

News

Frank­furt a. M. — A mid-cap fund advi­sed by Triton (Triton Smal­ler Mid-Cap Fund, “TSM”) has acqui­red a majo­rity stake in NORRES Group. With a team led by Dr. Pär Johans­son, Part­ner at the Colo­gne office, Heuking Kühn Lüer Wojtek provi­ded legal advice to Triton in connec­tion with the acqui­si­tion. The aim of the part­ner­ship is to expand NORRES’ expan­sion strategy.

NORRES is a manu­fac­tu­rer of indus­trial hoses with head­quar­ters in Gelsen­kir­chen and produc­tion sites in Germany, China and the USA. The indus­trial hoses are used for pneu­ma­tic convey­ing of various types of media such as solids, gases as well as liquids in diffe­rent indus­tries. Around 300 employees work for the company, which was foun­ded in 1889.

“We want to support NORRES by inves­t­ing in acce­le­ra­ted growth and the contin­ued inter­na­tio­na­liza­tion of the company. We look forward to working with the manage­ment team and contri­bu­ting our exper­tise and available resour­ces to further our shared vision of an even stron­ger company,” said Peder Prahl (pictu­red), Direc­tor of Gene­ral Part­ners for the Triton Funds.

About Triton
The Triton funds invest in medium-sized compa­nies based in Europe and support their posi­tive deve­lo­p­ment. They focus on compa­nies in the indus­trial, services and consu­mer goods/healthcare sectors.

Triton’s goal is to successfully deve­lop its port­fo­lio compa­nies in the long term by working toge­ther as part­ners. Triton and its manage­ment strive to gene­rate posi­tive change and growth through the sustainable impro­ve­ment of opera­tio­nal proces­ses and struc­tures. At present, Triton’s port­fo­lio includes 36 compa­nies with total sales of around EUR 12.7 billion and appro­xi­m­ately 82,000 employees. — The Triton funds are advi­sed by expe­ri­en­ced invest­ment profes­sio­nals based in Germany, Sweden, Norway, Finland, Denmark, Italy, the UK, the US, China, Luxem­bourg and Jersey. www.triton-partners.de

About NORRES
NORRES was foun­ded in 1889 and focu­ses on the deve­lo­p­ment, produc­tion and sale of indus­trial hoses for pneu­ma­tic convey­ing of diverse media types (e.g. solids, gases and liquids) for a variety of end markets (inclu­ding fume and dust extra­c­tion, agri­cul­ture, food & phar­maceu­ti­cals, plas­tics and wood proces­sing). The company is head­quar­te­red in Gelsen­kir­chen, Germany, and employs appro­xi­m­ately 300 people at three produc­tion sites (D, CN, USA) and five sales and warehouse loca­ti­ons (CZ, FR, PL, TW, GB).

Advi­sor to Triton: Heuking Kühn Lüer Wojtek
Dr. Pär Johans­son, Dr. Phil­ipp Jansen (both lead), Dr. Chris­toph Schork, LL.M., Tim Remmel, LL.M., (all Private Equity, Corporate/M&A), Dr. Verena Hoene, LL.M. (IP/IT), Dr. Sascha Sche­wiola (Labor Law), all Colo­gne; Dr. Kai Bandilla, Sen Gao (both Corporate/M&A), Fabian G. Gaffron (Tax), Dr. Frede­rik Wiemer (Anti­trust), all Hamburg; Mathis Dick, LL.M. (Real Estate), Düsseldorf

The team led by Colo­gne-based part­ner Dr. Pär Johans­son had alre­ady advi­sed Triton on the acqui­si­tion of BFC Group in Febru­ary 2018.

News

Frank­furt a. M. — German fintech company Vaamo Finanz AG, an online asset mana­ger based in Frank­furt, has joined forces with British compe­ti­tor Money­farm to form a close coope­ra­tion. In this context, Money­farm has acqui­red all shares in vaamo. Inter­na­tio­nal law firm Taylor Wessing, led by Frank­furt-based part­ner Dr. Lars-Gerrit Lüßmann, provi­ded legal advice to vaamo on the transaction.

vaamo and Money­farm want to build a pan-Euro­pean offe­ring in the field of digi­tal asset manage­ment toge­ther. Toge­ther, vaamo and Money­farm are active in three markets and can bundle market know­ledge and expe­ri­ence through the acqui­si­tion. Dr. Thomas Bloch (photo r.) and Dr. Oliver Vins (photo l.), foun­ders of vaamo, join the board of Moneyfarm.

vaamo is a digi­tal asset mana­ger with the goal of provi­ding custo­mers with simple, trans­pa­rent and cost-effec­tive access to the capi­tal market and the vision of making private asset invest­ment better and easier. The asset mana­ger offers a wide range of products to assist custo­mers with wealth manage­ment issues — in parti­cu­lar through the sale of insu­rance and capi­tal market products. vaamo has been on the market since 2014 and was the first inde­pen­dent online asset mana­ger in Germany at the time. vaamo has been advi­sed by Taylor Wessing in its finan­cing rounds since its inception.

Legal advi­sors vaamo: Taylor Wessing
Dr. Lars-Gerrit Lüßmann, Michael Sinhart (both lead), Li Alena Oppen­auer (all Corpo­rate, Frank­furt), Dr. Bert Kimpel (Tax, Düsseldorf)

About Taylor Wessing
Taylor Wessing is the corpo­rate name of a number of law firms that provide advice and services to clients world­wide, as well as other enti­ties affi­lia­ted with them. Each law firm is a sepa­rate and inde­pen­dent legal company or part­ner­ship and at the same time a member of the Taylor Wessing Asso­cia­tion or affi­lia­ted with such a member. With more than 1,100 lawy­ers in 32 offices* in Europe, the Middle East and Asia, as well as two repre­sen­ta­tive offices in the US, we provide market-leading inte­gra­ted legal advice to our clients from the world’s most dyna­mic and forward-looking industries.

News

Wolfsburg/ Stutt­gart — VW acqui­res 49 percent of German digi­tal specia­list Dico­nium. The Volks­wa­gen Group acqui­res a 49 percent stake in the German digi­tal specia­list dico­nium. With this invest­ment, the Volks­wa­gen Group secu­res further know-how and streng­thens its digi­tal busi­ness capa­bi­li­ties. Toge­ther, the two compa­nies will further deve­lop busi­ness models and Volkswagen’s range of digi­tal value-added services. dico­nium will thus become an important tech­no­logy part­ner for buil­ding new digi­tal services that will run in the Volks­wa­gen Auto­mo­tive Cloud. The comple­tion of the acqui­si­tion is still subject to appr­oval by the anti­trust authorities.

Accor­ding to VW, the aim is to be able to quickly offer car buyers digi­tal services such as wire­less updates or auto­ma­tic payment in fully networked vehic­les in the future. Toge­ther, the compa­nies also want to launch a sales plat­form through which VW custo­mers can buy and manage services and func­tions for connec­ted cars online. To do this, VW needs the exper­tise of its new part­ner, said Chris­toph Hartung, head of mobi­lity services at the Volks­wa­gen brand. — Dico­nium employs around 800 people in Germany, Portu­gal, the USA and India.

VW allo­ca­tes 44 billion euros for digitization
Among other things, VW is aiming to offer so-called over-the-air updates (wire­less updates via a radio inter­face) with the market launch of the elec­tric ID model family from 2020. A plan­ned elec­tro­nic sales plat­form is compa­ra­ble to a shop­ping mall with various stores.

News

Munich, Germany — AHT, the global market leader in commer­cial plug-in refri­ge­ra­tion and free­zer systems for food retail­ers, is being sold by private equity inves­tor Bridge­point to Daikin Europe N.V., a subsi­diary of Daikin Indus­tries Ltd. in Japan.

The company, head­quar­te­red in Rottenmann/Styria, Austria, is present in over 100 count­ries with its core products — ready-to-plug-in refri­ge­ra­tion and free­zer systems for the food retail sector. Commer­cial refri­ge­ra­tion equip­ment with built-in compres­sor (plug-in) is gradu­ally repla­cing equip­ment with exter­nal refri­ge­ra­tion compres­sor and is the fastest growing segment in the commer­cial food refri­ge­ra­tion and free­zer market. The advan­ta­ges of plug-in units are lower total cost of owner­ship as well as shorter instal­la­tion times. AHT looks back on an instal­led base of more than one million devices. In addi­tion to the sale of products, the company’s range of services includes the provi­sion of compre­hen­sive plan­ning, instal­la­tion and main­ten­ance services. The company’s four produc­tion sites are loca­ted in Austria, China, Brazil and the USA.

Bridge­point acqui­red AHT in Novem­ber 2013. The company gene­ra­ted net sales of €481 million for 2017 and has achie­ved average sales growth of 12% per year over the past 10 years.

Michael Davy, Part­ner at Bridge­point and Chair­man of AHT’s Board of Direc­tors, said, “AHT has evol­ved in recent years from a largely Euro­pean-focu­sed company to a global leader in its segment that conti­nues to expand its foot­print to include other attrac­tive inter­na­tio­nal markets. The company has been instru­men­tal in the indus­try-wide shift from units with exter­nal refri­ge­ra­tion compres­sors to plug-in systems. The latter are easier for custo­mers to install compared to tradi­tio­nal systems and are less expen­sive as well as more envi­ron­men­tally friendly to operate. We wish the company contin­ued success under its new owner­ship as it conti­nues to expand geogra­phi­cally and grow its product portfolio.”

Under Bridge­point, signi­fi­cant invest­ments have been made in the company. In the past three years alone, over 70 million euros have been inves­ted in the deve­lo­p­ment of new products, the expan­sion of produc­tion in Austria, and the estab­lish­ment of the new produc­tion faci­li­ties in Brazil and the USA. The expan­sion of produc­tion capa­city in China has also enab­led AHT to reduce its manu­fac­tu­ring costs while further expan­ding its market share in Europe.

Market obser­vers believe that plug-in refri­ge­ra­tion systems will conti­nue to outper­form the over­all global refri­ge­ra­tion market. This is due to the growing accep­tance of these systems, the upco­ming repla­ce­ment cycle of alre­ady instal­led equip­ment, and the incre­asing consu­mer demand for frozen and refri­ge­ra­ted food.

Frank Elsen, Mana­ging Direc­tor of AHT, added: “We have deve­lo­ped stron­gly since the invest­ment by Bridge­point more than four years ago and are now a market leader in our segment. We will not rest on our laurels and are plea­sed to have Daikin as our new owner, a part­ner who under­stands our busi­ness very well. Daikin supports our inno­va­tion stra­tegy and plan­ned further inter­na­tio­na­liza­tion, espe­ci­ally in emer­ging markets, which will allow us to offer AHT’s tech­no­logy and after-sales service to addi­tio­nal new custo­mer groups in our target markets in Asia and Latin America.”

Masa­tsugu Minaka, Presi­dent of Daikin Europe, said: “With this tran­sac­tion, Daikin adds AHT cooling systems to its compre­hen­sive range of proprie­tary air condi­tio­ning products, services and solu­ti­ons. This will enable Daikin to offer the complete range of air condi­tio­ning and cooling systems from a single source in the future. Refri­ge­ra­tion and free­zing systems are of great importance for one of the world’s most signi­fi­cant socie­tal chal­lenges — the shelf life of food and the reduc­tion of food waste, espe­ci­ally in emer­ging and deve­lo­ping count­ries. The cooling systems sector offers great poten­tial to our exis­ting advan­ced tech­no­lo­gies in energy conser­va­tion, heat exch­an­gers and refri­ge­ra­tion control.”

Advi­sors Bridge­point: Bridge­point was advi­sed on this tran­sac­tion by JP Morgan on M&A, PwC on finan­cing and tax, and Fresh­fields on legal.

About Bridge­point
Bridge­point is an inter­na­tio­nal private equity firm. With assets under manage­ment of 18 billion euros and capi­tal raised of over 28 billion euros, the company focu­ses on acqui­ring well-mana­ged compa­nies in growth sectors. Bridgepoint’s stra­tegy is to support busi­nesses and manage­ment teams by inves­t­ing in expan­sion, opera­tio­nal trans­for­ma­tion, or conso­li­da­tion through acquisitions.

News

Antwerp (BE) — Brussels-based Camel-IDS, which is deve­lo­ping novel radio­im­mu­no­the­rapy drugs to treat cancer, has closed a €37 million Series A finan­cing round — making it one of the larger rounds among early-stage life scien­ces compa­nies in Europe. Euro­pean private equity firm Gimv is the lead inves­tor toge­ther with V‑Bio Ventures, contri­bu­ting six million euros. Other inves­tors include Health­Cap, Novo Seeds, Ponti­fax and BioMed­Part­ners. With the new capi­tal, Camel-IDS plans to conduct a Phase Ib/II clini­cal trial for its lead deve­lo­p­ment candi­date in breast cancer with brain meta­sta­ses, as well as further expand its pre-clini­cal pipeline.

Camel-IDS (www.camel-ids.com) was foun­ded in 2014 as a spin-off of the Vrije Univer­si­teit Brussel (VUB). The company deve­lops novel radio­phar­maceu­ti­cals based on single domain anti­bo­dies linked to radi­o­nu­cli­des. Pati­ents with breast cancer whose tumors have an eleva­ted presence of the growth-promo­ting HER2 onco­pro­tein can now be trea­ted effec­tively and speci­fi­cally, but their progno­sis is extre­mely poor if the cancer spreads to the brain. The most advan­ced deve­lo­p­ment candi­date of Camel-IDS starts there: It is inten­ded to irra­diate corre­spon­ding brain lesi­ons effec­tively and without harming healthy tissue. This is based on a unique tech­no­logy plat­form that takes advan­tage of the favorable tissue distri­bu­tion of single domain anti­bo­dies asso­cia­ted with radi­o­nu­cli­des, as found in camelids.

Karl Nägler (photo), Part­ner of Gimv’s Health & Care plat­form., explains: “In our discus­sions, the great compe­tence of the Camel-IDS team in the field of radio-immu­no­the­rapy and the excep­tio­nal exper­tise of Profes­sor Tony Lahoutte became appa­rent early on. With CEO Ruth Deve­nyns, the company also has an accom­plished connois­seur of the Euro­pean biotech market and a successful entre­pre­neur. These are the best prere­qui­si­tes for the next stage of development.”

Gimv’s commit­ment is the company’s fourth invest­ment this year in the life scien­ces, medi­cal tech­no­logy and health­care sectors and unders­cores Gimv’s role as one of the most active inves­tors in the Euro­pean health­care indus­try. This brings the number of port­fo­lio compa­nies in Gimv’s Health & Care plat­form to 21.

About Gimv
Gimv is a Euro­pean invest­ment firm with nearly 40 years of expe­ri­ence in private equity and venture capi­tal. The company is listed on Euron­ext Brussels, curr­ently mana­ges around EUR 1.6 billion and curr­ently invests in around 50 port­fo­lio compa­nies, which toge­ther gene­rate reve­nues of more than EUR 2.5 billion and employ more than 14,000 people.

Gimv iden­ti­fies inno­va­tive, leading compa­nies with high growth poten­tial and supports them on their way to market leader­ship. Each of the four invest­ment plat­forms Connec­ted Consu­mer, Health & Care, Smart Indus­tries and Sustainable Cities is mana­ged by a dedi­ca­ted and compe­tent team, each based in Gimv’s home markets — Bene­lux, France and DACH — and supported by an exten­sive inter­na­tio­nal network of experts.
For more infor­ma­tion about Gimv, visit www.gimv.com.

News

Berlin — The Berlin-based startup Solvemate has raised a seven-figure sum as part of a growth finan­cing. The finan­cing round was led by venture capi­ta­lists Picea Capi­tal and Venture Stars.

Solvemate offers a virtual assistant to auto­mate custo­mer service in compa­nies. In the coming year, Solvemate plans to drive its growth and triple its reve­nue. Speci­fi­cally, the money from the finan­cing round is to be used for further tech­no­lo­gi­cal deve­lo­p­ment and to expand marketing.

Solvemate also plans to incre­asingly acquire custo­mers from the Euro­pean region, focu­sing prima­rily on the DACH region. Solvemate is also inves­t­ing the new capi­tal in the algo­rithm and new marke­ting acti­vi­ties. The company, foun­ded in Berlin in 2015, had alre­ady recei­ved funding from Venture Stars in the past. The rene­wed finan­cial support thus demons­tra­tes Venture Stars’ satis­fac­tion with Solvemate’s deve­lo­p­ment. Picea Capi­tal from Hamburg, on the other hand, is a new inves­tor. — Venture capi­ta­lists Picea Capi­tal and Venture Stars are inves­t­ing the sum to acce­le­rate the growth of the startup, which was foun­ded in 2015. The start-up, foun­ded by Erik Pfan­nem­öl­ler (photo), curr­ently has 30 employees. The money is to be used for the further deve­lo­p­ment of the tech­no­logy — but above all for marke­ting, in order to make Solvemate better known in Germany, Austria and Switzerland.

About Solvemate GmbH
Solvemate (www.solvemate.com) is a tech­no­logy company that auto­ma­tes corpo­rate custo­mer service with its virtual assistant. Using a combi­na­tion of arti­fi­cial intel­li­gence and machine lear­ning, Solvemate’s soft­ware can correctly answer custo­mer queries in an average of 12 seconds and 83 percent of the time. Custo­mers thus receive a targe­ted response quickly, while compa­nies bene­fit from a signi­fi­cant reduc­tion in costs. Users alre­ady include Berli­ner Spar­kasse and the startup SumUp, among others. Solvemate was foun­ded in 2015 by Erik Pfannmöl­ler. The company is based in Berlin and curr­ently employs 30 people.

LUTZ | ABEL repre­sen­ted Solvemate through its two venture capi­tal experts Dr. Marco Eick­mann and Phil­ipp Hoene. Advi­sor Solvemate: Dr. Marco Eick­mann, LL.M. (Part­ner), Phil­ipp Hoene (Asso­ciate)

About LUTZ | ABEL
With around 60 lawy­ers and offices in Munich, Hamburg and Stutt­gart, the commer­cial law firm LUTZ | ABEL provi­des advice on all aspects of commer­cial law. For more infor­ma­tion, visit www.lutzabel.com

News

Munich — As of Novem­ber 15, 2018, Dipl.-Ing. Karl Chris­tian Vogel (54, photo) will take over the posi­tion of Mana­ging Direc­tor of BayBG Baye­ri­sche Betei­li­gungs­ge­sell­schaft. This means that BayBG’s manage­ment board is once again complete, after Peter Pauli took over as spokes­man for the manage­ment board on Octo­ber 1.

Karl Chris­tian Vogel has deca­des of expe­ri­ence in the consul­ting and invest­ment busi­ness. After study­ing mecha­ni­cal engi­nee­ring, he began his profes­sio­nal career in 1992 at the consul­ting firm CIM Manage­ment, which focu­ses on medium-sized indus­trial compa­nies. There he successfully imple­men­ted seve­ral restruc­tu­ring projects, among others at Schott in Mainz. From 1996, he was head of orga­niza­tio­nal deve­lo­p­ment at Brose Fahr­zeug­teile GmbH & Co. KG, Coburg. This was follo­wed by further posi­ti­ons at 3i Deutsch­land, Frank­furt, and at a prede­ces­sor company of today’s Süd Betei­li­gun­gen GmbH (SüdBG), Stutt­gart, where he was Mana­ging Direc­tor until the end of 2017.

In his career, Karl Chris­tian Vogel and his teams have assis­ted more than 50 medium-sized compa­nies with succes­si­ons, growth projects and asset diver­si­fi­ca­tion with equity and mezza­nine and finan­ced around 80 tech­no­logy start-ups.

“I am deligh­ted,” says Peter Pauli, “that we have been able to win Karl Chris­tian Vogel, such an estab­lished mana­ger with expe­ri­ence in the invest­ment busi­ness, as Mana­ging Direc­tor. Toge­ther we will work to further expand BayBG’s posi­tion as a compe­tent, effi­ci­ent and market-leading invest­ment part­ner for Bava­rian SMEs.”

About BayBG
With an inves­ted volume of more than 300 million euros, BayBG Baye­ri­sche Betei­li­gungs­ge­sell­schaft is one of the largest provi­ders of equity capi­tal for Bava­rian SMEs. With its venture capi­tal and equity invest­ments, which it provi­des in the form of equity and mezza­nine, it enables medium-sized compa­nies to imple­ment inno­va­tion and growth projects, manage corpo­rate succes­sion or opti­mize their capi­tal structure.

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de